II 

Calendar No. 369 

114TH CONGRESS 

2D SESSION S. 524 

To authorize the Attorney General to award grants to address the national 

epidemics of prescription opioid abuse and heroin use. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 12, 2015 

Mr. WHITEHOUSE (for himself, Mr. PORTMAN, Ms. KLOBUCHAR, Ms. 

AYOTTE, Mr. COONS, Mr. KIRK, Mr. NELSON, Ms. WARREN, Mr. 

FRANKEN, Mrs. FEINSTEIN, Mr. SCHUMER, Mrs. GILLIBRAND, Ms. COLLINS, Mr. HATCH, Mr. GRAHAM, Ms. BALDWIN, Mr. MENENDEZ, Mrs. 

SHAHEEN, Mr. KING, Mr. MANCHIN, Mr. BLUMENTHAL, Mr. LEAHY, 

Mrs. CAPITO, Mr. DONNELLY, Mr. SULLIVAN, Mr. HEINRICH, Mr. 

TESTER, Mr. RUBIO, Mr. UDALL, Mr. DURBIN, Mr. GRASSLEY, Mr. CORNYN, and Mr. BLUNT) introduced the following bill; which was read twice 

and referred to the Committee on the Judiciary 

FEBRUARY 22, 2016 

Reported by Mr. GRASSLEY, with an amendment 

[Strike out all after the enacting clause and insert the part printed in italic] 

A BILL 

To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse 

and heroin use. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•S 524 RS

1 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

2 (a) SHORT TITLE.—This Act may be cited as the 

3 ‘‘Comprehensive Addiction and Recovery Act of 2015’’. 

4 (b) TABLE OF CONTENTS.—The table of contents for 

5 this Act is as follows: 

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 

Sec. 3. Definitions. 

TITLE I—PREVENTION AND EDUCATION 

Sec. 101. Development of best prescribing practices. 

Sec. 102. National education campaign. 

Sec. 103. Community-based coalition enhancement grants to address local drug 

crises. 

TITLE II—LAW ENFORCEMENT AND TREATMENT 

Sec. 201. Treatment alternative to incarceration programs. 

Sec. 202. Law enforcement naloxone training and implementation demonstration. 

Sec. 203. Prescription drug take back expansion. 

TITLE III—TREATMENT AND RECOVERY 

Sec. 301. Evidence-based opioid and heroin treatment and interventions demonstration. 

Sec. 302. Criminal justice medication assisted treatment and interventions demonstration. 

Sec. 303. National youth recovery initiative. 

Sec. 304. Building communities of recovery. 

TITLE IV—ADDRESSING COLLATERAL CONSEQUENCES 

Sec. 401. Correctional education demonstration grant program. 

Sec. 402. Revision of FAFSA form. 

Sec. 403. National Task Force on Recovery and Collateral Consequences. 

TITLE V—ADDICTION AND TREATMENT SERVICES FOR WOMEN, 

FAMILIES, AND VETERANS 

Sec. 501. Authority to award competitive grants to address opioid and heroin 

abuse by pregnant and parenting female offenders. 

Sec. 502. Grants for family-based substance abuse treatment. 

Sec. 503. Veterans’ treatment courts. 

TITLE VI—INCENTIVIZING STATE COMPREHENSIVE INITIATIVES 

TO ADDRESS OPIOID AND HEROIN ABUSE 

Sec. 601. State demonstration grants for comprehensive opioid abuse response. 

TITLE VII—OFFSET; GAO REPORT 

mstockstill on DSK4VPTVN1PROD with BILLS

3 

•S 524 RS

Sec. 701. Offset. 

Sec. 702. GAO report on IMD exclusion. 

1 SEC. 2. FINDINGS. 

2 Congress finds the following: 

3 (1) The abuse of heroin and prescription pain4 killers is having a devastating effect on public health 

5 and safety in communities across the United States. 

6 According to the Centers for Disease Control and 

7 Prevention, drug overdose deaths now surpass traffic 

8 crashes in the number of deaths caused by injury in 

9 the United States. In 2011, an average of about 110 

10 people in the United States died from drug overdose 

11 every day. 

12 (2) Law enforcement officials and treatment ex13 perts throughout the country report that many pre14 scription opioid users have turned to heroin as a 

15 cheaper or more easily obtained alternative to pre16 scription drugs. 

17 (3) Opioid pain relievers are the most widely 

18 misused or abused controlled prescription drugs 

19 (commonly referred to as ‘‘CPDs’’) and are involved 

20 in most CPD-related overdose incidents. According 

21 to the Drug Abuse Warning Network (commonly 

22 known as ‘‘DAWN’’), the estimated number of emer23 gency department visits involving nonmedical use of 

24 prescription opiates or opioids increased by 112 permstockstill on DSK4VPTVN1PROD with BILLS

4 

•S 524 RS

1 cent between 2006 and 2010, from 84,671 to 

2 179,787. 

3 (4) According to a report by the National Asso4 ciation of State Alcohol and Drug Abuse Directors 

5 (commonly referred to as ‘‘NASADAD’’), 37 States 

6 reported an increase in admissions to treatment for 

7 heroin use during the past 2 years, while admissions 

8 to treatment for prescription opiates increased 500 

9 percent from 2000 to 2012. 

10 (5) Substance use disorders are a treatable dis11 ease. Discoveries in the science of addiction have led 

12 to advances in the treatment of substance use dis13 orders that help people stop abusing drugs and pre14 scription medications and resume their productive 

15 lives. 

16 (6) According to the National Survey on Drug 

17 Use and Health, approximately 22,700,000 people in 

18 the United States needed substance use disorder 

19 treatment in 2013, but only 2,500,000 people re20 ceived it. Furthermore, current treatment services 

21 are not adequate to meet demand. According to a re22 port commissioned by SAMHSA, there are approxi23 mately 32 providers for every 1,000 individuals 

24 needing substance use disorder treatment. In some 

25 States, the ratio is much lower. 

mstockstill on DSK4VPTVN1PROD with BILLS

5 

•S 524 RS

1 (7) Effective substance abuse prevention can 

2 yield major economic dividends. 

3 (8) According to the National Institute on Drug 

4 Abuse, when schools and communities properly im5 plement science-validated substance abuse prevention 

6 programs, abuse of alcohol, tobacco, and illicit drugs 

7 is reduced. Such programs help teachers, parents, 

8 and healthcare professionals shape the perceptions 

9 of youths about the risks of drug abuse. 

10 (9) Diverting individuals with substance use 

11 disorders from criminal justice systems into commu12 nity-based treatment can save billions of dollars and 

13 prevent sizeable numbers of crimes, arrests, and re14 incarcerations over the course of those individuals’ 

15 lives. 

16 (10) According to the Drug Enforcement Agen17 cy, more than 1,700 tons of expired, unwanted pre18 scription medications have been collected during the 

past 31 19 ⁄2 years, following the enactment of the Se20 cure and Responsible Drug Disposal Act of 2010 

21 (Public Law 111–273; 124 Stat. 2858). 

22 (11) Research shows that combining treatment 

23 medications with behavioral therapy is the best way 

24 to facilitate success for most patients. Treatment ap25 proaches must be tailored to address the drug abuse 

mstockstill on DSK4VPTVN1PROD with BILLS

6 

•S 524 RS

1 patterns and drug-related medical, psychiatric, and 

2 social problems of each individual. Different types of 

3 medications may be useful at different stages of 

4 treatment or recovery to help a patient stop using 

5 drugs, stay in treatment, and avoid relapse. 

6 (12) Research indicates that combating the 

7 opioid crisis, including abuse of prescription pain8 killers and, increasingly, heroin, requires a multi9 pronged approach that involves reducing drug diver10 sion, expanding delivery of existing treatments (in11 cluding medication assisted treatments), expanding 

12 access to overdose medications and interventions, 

13 and the development of new medications for pain 

14 that can augment the existing treatment arsenal. 

15 (13) Individuals with mental illness, especially 

16 severe mental illness, are at considerably higher risk 

17 for substance abuse than the general population, and 

18 the presence of a mental illness complicates recovery 

19 from substance abuse. 

20 SEC. 3. DEFINITIONS. 

21 In this Act— 

22 (1) the term ‘‘medication assisted treatment’’ 

23 means the use, for problems relating to heroin and 

24 other opioids, of medications approved by the Food 

mstockstill on DSK4VPTVN1PROD with BILLS

7 

•S 524 RS

1 and Drug Administration in combination with coun2 seling and behavioral therapies; 

3 (2) the term ‘‘ONDCP Recovery Branch’’ 

4 means the Recovery Branch of the Office of Na5 tional Drug Control Policy; 

6 (3) the term ‘‘opioid’’ means any drug having 

7 an addiction-forming or addiction-sustaining liability 

8 similar to morphine or being capable of conversion 

9 into a drug having such addiction-forming or addic10 tion-sustaining liability; and 

11 (4) the term ‘‘State’’ means any State of the 

12 United States, the District of Columbia, the Com13 monwealth of Puerto Rico, and any territory or pos14 session of the United States. 

15 TITLE I—PREVENTION AND 

16 EDUCATION 

17 SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRAC18 TICES. 

19 (a) INTER-AGENCY TASK FORCE.—Not later than 

20 120 days after the date of enactment of this Act, the Sec21 retary of Health and Human Services (referred to in this 

22 section as the ‘‘Secretary’’), in cooperation with the Sec23 retary of Veterans Affairs, the Secretary of Defense, and 

24 the Administrator of the Drug Enforcement Administra25 tion, shall convene a Pain Management Best Practices 

mstockstill on DSK4VPTVN1PROD with BILLS

8 

•S 524 RS

1 Inter-Agency Task Force (referred to in this section as 

2 the ‘‘task force’’). 

3 (b) MEMBERSHIP.—The task force shall be com4 prised of— 

5 (1) representatives of— 

6 (A) the Department of Health and Human 

7 Services; 

8 (B) the Department of Veterans Affairs; 

9 (C) the Department of Defense; 

10 (D) the Drug Enforcement Administration; 

11 (E) the Centers for Disease Control and 

12 Prevention; 

13 (F) the Institute of Medicine; and 

14 (G) the Office of National Drug Control 

15 Policy; 

16 (2) the Director of the National Institutes of 

17 Health; 

18 (3) physicians, dentists, and non-physician pre19 scribers; 

20 (4) pharmacists; 

21 (5) experts in the fields of pain research and 

22 addiction research; 

23 (6) representatives of— 

24 (A) pain management professional organi25 zations; 

mstockstill on DSK4VPTVN1PROD with BILLS

9 

•S 524 RS

1 (B) the mental health treatment commu2 nity; 

3 (C) the addiction treatment community; 

4 (D) pain advocacy groups; and 

5 (E) groups with expertise around overdose 

6 reversal; and 

7 (7) other stakeholders, as the Secretary deter8 mines appropriate. 

9 (c) DUTIES.—The task force shall— 

10 (1) not later than 180 days after the date on 

11 which the task force is convened under subsection 

12 (a), develop best practices for pain management (in13 cluding chronic and acute pain) and prescribing pain 

14 medication, taking into consideration— 

15 (A) existing pain management research; 

16 (B) recommendations from relevant con17 ferences; 

18 (C) ongoing efforts at the State and local 

19 levels and by medical professional organizations 

20 to develop improved pain management strate21 gies; and 

22 (D) the management of high-risk popu23 lations, other than populations who suffer pain, 

24 who— 

mstockstill on DSK4VPTVN1PROD with BILLS

10 

•S 524 RS

1 (i) may use or be prescribed 

2 benzodiazepines, alcohol, and diverted 

3 opioids; or 

4 (ii) receive opioids in the course of 

5 medical care; 

6 (2) solicit and take into consideration public 

7 comment on the practices developed under para8 graph (1), amending such best practices if appro9 priate; and 

10 (3) develop a strategy for disseminating infor11 mation about the best practices developed under 

12 paragraphs (1) and (2) to prescribers, health profes13 sionals, pharmacists, State medical boards, and 

14 other parties, as the Secretary determines appro15 priate. 

16 (d) LIMITATION.—The task force shall not have rule17 making authority. 

18 (e) REPORT.—Not later than 270 days after the date 

19 on which the task force is convened under subsection (a), 

20 the task force shall submit to Congress a report that in21 cludes— 

22 (1) the strategy for disseminating best practices 

23 developed under subsection (c); 

24 (2) the results of a feasibility study on linking 

25 best practices developed under subsection (c) to remstockstill on DSK4VPTVN1PROD with BILLS

11 

•S 524 RS

1 ceiving and renewing registrations under section 

2 303(f) of the Controlled Substances Act (21 U.S.C. 

3 823(f)); and 

4 (3) recommendations on how to apply best 

5 practices developed under subsection (c) to improve 

6 prescribing practices at medical facilities, including 

7 medical facilities of the Veterans Health Administra8 tion. 

9 SEC. 102. NATIONAL EDUCATION CAMPAIGN. 

10 Title I of the Omnibus Crime Control and Safe 

11 Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amended 

12 by adding at the end the following: 

13 ‘‘PART MM—DRUG TREATMENT GRANTS 

14 ‘‘SEC. 3031. DEFINITIONS. 

15 ‘‘In this part— 

16 ‘‘(1) the term ‘civil liability protection law’ 

17 means a State law that protects from civil liability 

18 individuals who give aid on a voluntary basis in an 

19 emergency to individuals who are ill, in peril, or oth20 erwise incapacitated; 

21 ‘‘(2) the term ‘medication assisted treatment’ 

22 means the use, for problems relating to heroin and 

23 other opioids, of medications approved by the Food 

24 and Drug Administration in combination with coun25 seling and behavioral therapies; 

mstockstill on DSK4VPTVN1PROD with BILLS

12 

•S 524 RS

1 ‘‘(3) the term ‘opioid’ means any drug having 

2 an addiction-forming or addiction-sustaining liability 

3 similar to morphine or being capable of conversion 

4 into a drug having such addiction-forming or addic5 tion-sustaining liability; and 

6 ‘‘(4) the term ‘Single State Authority for Sub7 stance Abuse’ has the meaning given the term in 

8 section 201(e) of the Second Chance Act of 2007 

9 (42 U.S.C. 17521(e)). 

10 ‘‘SEC. 3032. NATIONAL EDUCATION CAMPAIGN. 

11 ‘‘(a) DEFINITIONS.—In this section— 

12 ‘‘(1) the term ‘eligible entity’ means a State, 

13 unit of local government, or nonprofit organization; 

14 and 

15 ‘‘(2) the terms ‘elementary school’ and ‘sec16 ondary school’ have the meaning given those terms 

17 in section 9101 of the Elementary and Secondary 

18 Education Act of 1965 (20 U.S.C. 7801). 

19 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen20 eral, in coordination with the Secretary of Health and 

21 Human Services, the Director of the Office of National 

22 Drug Control Policy, the Secretary of Education, the Ad23 ministrator of the Substance Abuse and Mental Health 

24 Services Administration, and the Director of the Centers 

25 for Disease Control and Prevention, may make grants to 

mstockstill on DSK4VPTVN1PROD with BILLS

13 

•S 524 RS

1 eligible entities to expand educational efforts to prevent 

2 abuse of opioids, heroin, and other substances of abuse, 

3 understand addiction as a chronic disease, and promote 

4 treatment and recovery, including— 

5 ‘‘(1) parent and caretaker-focused prevention 

6 efforts, including— 

7 ‘‘(A) the development of research-based 

8 community education online and social media 

9 materials with an accompanying toolkit that 

10 can be disseminated to communities to educate 

11 parents and other caretakers of teens on— 

12 ‘‘(i) how to educate teens about opioid 

13 and heroin abuse; 

14 ‘‘(ii) how to intervene if a parent 

15 thinks or knows their teen is abusing 

16 opioids or heroin; 

17 ‘‘(iii) signs of opioid or heroin over18 dose; and 

19 ‘‘(iv) the use of naloxone to prevent 

20 death from opioid or heroin overdose; 

21 ‘‘(B) the development of detailed digital 

22 and print educational materials to accompany 

23 the online and social media materials and tool24 kit described in subparagraph (A); 

mstockstill on DSK4VPTVN1PROD with BILLS

14 

•S 524 RS

1 ‘‘(C) the development and dissemination of 

2 public service announcements to— 

3 ‘‘(i) raise awareness of heroin and 

4 opioid abuse among parents and other 

5 caretakers; 

6 ‘‘(ii) motivate parents and other care7 takers to visit online educational materials 

8 on heroin and opioid abuse; and 

9 ‘‘(iii) provide information for public 

10 health agencies and nonprofit organiza11 tions that provide overdose reversal and 

12 prevention services and community refer13 rals; and 

14 ‘‘(D) the dissemination of educational ma15 terials to the media through— 

16 ‘‘(i) a town hall or panel discussion 

17 with experts; 

18 ‘‘(ii) a press release; 

19 ‘‘(iii) an online news release; 

20 ‘‘(iv) a media tour; and 

21 ‘‘(v) sharable infographics; 

22 ‘‘(2) prevention efforts focused on teenagers, 

23 young adults, and college students, including the de24 velopment of— 

25 ‘‘(A) a national digital campaign; 

mstockstill on DSK4VPTVN1PROD with BILLS

15 

•S 524 RS

1 ‘‘(B) a community education toolkit for use 

2 by community coalitions; 

3 ‘‘(C) evidence-based resources for preven4 tion and treatment professionals targeting indi5 viduals who are between 18 and 24 years of 

6 age, including college students; and 

7 ‘‘(D) technical support centers for preven8 tion and treatment professionals, elementary 

9 and secondary school-based professionals, and 

10 college-based professionals, including recovery 

11 staff, to implement and sustain evidence-based 

12 educational and prevention programs; 

13 ‘‘(3) campaigns to inform individuals about 

14 available resources to aid in recovery from substance 

15 use disorder; 

16 ‘‘(4) encouragement of individuals in or seeking 

17 recovery from substance use disorder to enter the 

18 health care system; or 

19 ‘‘(5) adult-focused awareness efforts, including 

20 efforts focused on older adults, relating to prescrip21 tion medication disposal, opioid and heroin abuse, 

22 signs of overdose, and the use of naloxone for rever23 sal. 

24 ‘‘(c) APPLICATION.— 

mstockstill on DSK4VPTVN1PROD with BILLS

16 

•S 524 RS

1 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

2 grant under this section shall submit an application 

3 to the Attorney General— 

4 ‘‘(A) that meets the criteria under para5 graph (2); and 

6 ‘‘(B) at such time, in such manner, and 

7 accompanied by such information as the Attor8 ney General may require. 

9 ‘‘(2) CRITERIA.—An eligible entity, in submit10 ting an application under paragraph (1), shall— 

11 ‘‘(A) describe the evidence-based method12 ology and outcome measurements that will be 

13 used to evaluate the program funded with a 

14 grant under this section; 

15 ‘‘(B) specifically explain how the measure16 ments described in subparagraph (A) will pro17 vide valid measures of the impact of the pro18 gram described in subparagraph (A); 

19 ‘‘(C) describe how the program described 

20 in subparagraph (A) could be broadly replicated 

21 if demonstrated to be effective; 

22 ‘‘(D) demonstrate that all planned services 

23 will be research-informed, which may include 

24 evidence-based practices documented in— 

mstockstill on DSK4VPTVN1PROD with BILLS

17 

•S 524 RS

1 ‘‘(i) the report of the Institute of 

2 Medicine entitled ‘Preventing Mental, 

3 Emotional, and Behavioral Disorders 

4 Among Young People’; or 

5 ‘‘(ii) the National Registry of Effec6 tive Programs and Practices (commonly re7 ferred to as ‘NREPP’) of the Substance 

8 Abuse and Mental Health Administration; 

9 and 

10 ‘‘(E) demonstrate that the eligible entity 

11 will effectively integrate and sustain the pro12 gram described in subparagraph (A) into cur13 riculum or community outreach efforts. 

14 ‘‘(d) USE OF FUNDS.—A grantee shall use a grant 

15 received under this section for expenses of educational ef16 forts to— 

17 ‘‘(1) prevent abuse of opioids, heroin, alcohol, 

18 and other drugs; or 

19 ‘‘(2) promote treatment and recovery. 

20 ‘‘(e) DURATION.—The Attorney General shall award 

21 grants under this section for a period not to exceed 2 

22 years. 

23 ‘‘(f) PRIORITY CONSIDERATION WITH RESPECT TO

24 STATES.—In awarding grants to States under this sec25 tion, the Attorney General shall give priority to a State 

mstockstill on DSK4VPTVN1PROD with BILLS

18 

•S 524 RS

1 that provides civil liability protection for first responders, 

2 health professionals, and family members administering 

3 naloxone to counteract opioid overdoses by— 

4 ‘‘(1) enacting legislation that provides such civil 

5 liability protection; or 

6 ‘‘(2) providing a certification by the attorney 

7 general of the State that the attorney general has— 

8 ‘‘(A) reviewed any applicable civil liability 

9 protection law to determine the applicability of 

10 the law with respect to first responders, health 

11 care professionals, family members, and other 

12 individuals who may administer naloxone to in13 dividuals reasonably believed to be suffering 

14 from opioid overdose; and 

15 ‘‘(B) concluded that the law described in 

16 subparagraph (A) provides adequate civil liabil17 ity protection applicable to such persons. 

18 ‘‘(g) INFORMATION SHARING.—The Office of the At19 torney General, in coordination with the Substance Abuse 

20 and Mental Health Services Administration and the De21 partment of Education, shall review existing evidence22 based programs and emerging practices and programs and 

23 provide information to schools and communities about 

24 such programs and practices. 

mstockstill on DSK4VPTVN1PROD with BILLS

19 

•S 524 RS

1 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $2,500,000 for each of fiscal years 2016 through 2020.’’. 

4 SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 

5 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

6 Part MM of title I of the Omnibus Crime Control 

7 and Safe Streets Act of 1968, as added by section 102, 

8 is amended by adding at the end the following: 

9 ‘‘SEC. 3033. COMMUNITY-BASED COALITION ENHANCEMENT 

10 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

11 ‘‘(a) DEFINITIONS.—In this section— 

12 ‘‘(1) the term ‘Drug-Free Communities Act of 

13 1997’ means chapter 2 of the National Narcotics 

14 Leadership Act of 1988 (21 U.S.C. 1521 et seq.); 

15 ‘‘(2) the term ‘eligible entity’ means an organi16 zation that— 

17 ‘‘(A) on or before the date of submitting 

18 an application for a grant under this section, 

19 receives or has received a grant under the 

20 Drug-Free Communities Act of 1997; and 

21 ‘‘(B) has documented, using local data, 

22 rates of abuse of opioids at levels that are— 

23 ‘‘(i) significantly higher than the na24 tional average as determined by the Attor25 ney General (including appropriate considmstockstill on DSK4VPTVN1PROD with BILLS

20 

•S 524 RS

1 eration of the Monitoring the Future Sur2 vey published by the National Institute on 

3 Drug Abuse and the National Survey on 

4 Drug Use and Health by the Substance 

5 Abuse and Mental Health Service Adminis6 tration); or 

7 ‘‘(ii) higher than the national average, 

8 as determined by the Attorney General (in9 cluding appropriate consideration of the 

10 surveys described in clause (i)), over a sus11 tained period of time; and 

12 ‘‘(3) the term ‘local drug crisis’ means, with re13 spect to the area served by an eligible entity— 

14 ‘‘(A) a sudden increase in the abuse of 

15 opioids, as documented by local data; or 

16 ‘‘(B) the abuse of prescription medications, 

17 specifically opioids, that is significantly higher 

18 than the national average, over a sustained pe19 riod of time, as documented by local data. 

20 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen21 eral, in coordination with the Director, may make grants 

22 to eligible entities to implement comprehensive commu23 nity-wide strategies that address local drug crises within 

24 the area served by the eligible entity. 

25 ‘‘(c) APPLICATION.— 

mstockstill on DSK4VPTVN1PROD with BILLS

21 

•S 524 RS

1 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

2 grant under this section shall submit an application 

3 to the Attorney General at such time, in such man4 ner, and accompanied by such information as the 

5 Attorney General may require. 

6 ‘‘(2) CRITERIA.—As part of an application for 

7 a grant under this section, the Attorney General 

8 shall require an eligible entity to submit a detailed, 

9 comprehensive, multi-sector plan for addressing the 

10 local drug crisis within the area served by the eligi11 ble entity. 

12 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

13 grant received under this section— 

14 ‘‘(1) for programs designed to implement com15 prehensive community-wide prevention strategies to 

16 address local drug crisis in the area served by the 

17 eligible entity, in accordance with the plan submitted 

18 under subsection (c)(2); and 

19 ‘‘(2) to obtain specialized training and technical 

20 assistance from the organization funded under sec21 tion 4 of Public Law 107–82 (21 U.S.C. 1521 note). 

22 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

23 ‘‘(1) AMOUNTS.—The Attorney General may 

24 not award a grant under this section for a fiscal 

25 year in an amount that exceeds— 

mstockstill on DSK4VPTVN1PROD with BILLS

22 

•S 524 RS

1 ‘‘(A) the amount of non-Federal funds 

2 raised by the eligible entity, including in-kind 

3 contributions, for that fiscal year; or 

4 ‘‘(B) $75,000. 

5 ‘‘(2) DURATION.—The Attorney General shall 

6 award grants under this section for a period not to 

7 exceed 4 years. 

8 ‘‘(f) SUPPLEMENT NOT SUPPLANT.—An eligible enti9 ty shall use Federal funds received under this section only 

10 to supplement the funds that would, in the absence of 

11 those Federal funds, be made available from other Federal 

12 and non-Federal sources for the activities described in this 

13 section, and not to supplant those funds. 

14 ‘‘(g) EVALUATION.—A grant under this section shall 

15 be subject to the same evaluation requirements and proce16 dures as the evaluation requirements and procedures im17 posed on the recipient of a grant under the Drug-Free 

18 Communities Act of 1997. 

19 ‘‘(h) LIMITATION ON ADMINISTRATIVE EXPENSES.— 

20 Not more than 8 percent of the amounts made available 

21 pursuant to subsection (i) for a fiscal year may be used 

22 by the Attorney General to pay for administrative ex23 penses. 

mstockstill on DSK4VPTVN1PROD with BILLS

23 

•S 524 RS

1 ‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

4 TITLE II—LAW ENFORCEMENT 

5 AND TREATMENT 

6 SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 

7 PROGRAMS. 

8 Part MM of the Omnibus Crime Control and Safe 

9 Streets Act of 1968, as amended by section 103, is amend10 ed by adding at the end the following: 

11 ‘‘SEC. 3034. TREATMENT ALTERNATIVE TO INCARCERATION 

12 PROGRAMS. 

13 ‘‘(a) DEFINITIONS.—In this section— 

14 ‘‘(1) the term ‘eligible entity’ means a State, 

15 unit of local government, Indian tribe, or nonprofit 

16 organization; and 

17 ‘‘(2) the term ‘eligible participant’ means an in18 dividual who— 

19 ‘‘(A) comes into contact with the juvenile 

20 justice system or criminal justice system or is 

21 arrested or charged with an offense; 

22 ‘‘(B) has a history of or a current— 

23 ‘‘(i) substance use disorder; 

24 ‘‘(ii) mental illness; or 

mstockstill on DSK4VPTVN1PROD with BILLS

24 

•S 524 RS

1 ‘‘(iii) co-occurring mental illness and 

2 substance use disorders; and 

3 ‘‘(C) has been approved for participation in 

4 a program funded under this section by, as ap5 plicable depending on the stage of the criminal 

6 justice process, the relevant law enforcement 

7 agency or prosecuting attorney, defense attor8 ney, probation or corrections official, judge, or 

9 representative from the relevant mental health 

10 or substance abuse agency. 

11 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney General 

12 may make grants to eligible entities to develop, implement, 

13 or expand a treatment alternative to incarceration pro14 gram for eligible participants, including— 

15 ‘‘(1) pre-booking treatment alternative to incar16 ceration programs, including— 

17 ‘‘(A) law enforcement training on sub18 stance use disorders, mental illness, and co-oc19 curring mental illness and substance use dis20 orders; 

21 ‘‘(B) receiving centers as alternatives to in22 carceration of eligible participants; 

23 ‘‘(C) specialized response units for calls re24 lated to substance use disorders, mental illness, 

mstockstill on DSK4VPTVN1PROD with BILLS

25 

•S 524 RS

1 and co-occurring mental illness and substance 

2 use disorders; and 

3 ‘‘(D) other arrest and pre-booking treat4 ment alternative to incarceration models; and 

5 ‘‘(2) post-booking treatment alternative to in6 carceration programs, including— 

7 ‘‘(A) specialized clinical case management; 

8 ‘‘(B) pre-trial services related to sub9 stances use disorders, mental illness, and co-oc10 curring mental illness and substance use dis11 orders; 

12 ‘‘(C) prosecutor and defender based pro13 grams; 

14 ‘‘(D) specialized probation; 

15 ‘‘(E) programs utilizing the American So16 ciety of Addiction Medicine patient placement 

17 criteria; 

18 ‘‘(F) treatment and rehabilitation pro19 grams and recovery support services; and 

20 ‘‘(G) drug courts, DWI courts, and vet21 erans treatment courts. 

22 ‘‘(c) APPLICATION.— 

23 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

24 grant under this section shall submit an application 

25 to the Attorney General— 

mstockstill on DSK4VPTVN1PROD with BILLS

26 

•S 524 RS

1 ‘‘(A) that meets the criteria under para2 graph (2); and 

3 ‘‘(B) at such time, in such manner, and 

4 accompanied by such information as the Attor5 ney General may require. 

6 ‘‘(2) CRITERIA.—An eligible entity, in submit7 ting an application under paragraph (1), shall— 

8 ‘‘(A) provide extensive evidence of collabo9 ration with State and local government agencies 

10 overseeing health, community corrections, 

11 courts, prosecution, substance abuse, mental 

12 health, victims services, and employment serv13 ices, and with local law enforcement agencies; 

14 ‘‘(B) demonstrate consultation with the 

15 Single State Authority for Substance Abuse; 

16 ‘‘(C) demonstrate that evidence-based 

17 treatment practices will be utilized; and 

18 ‘‘(D) demonstrate that evidenced-based 

19 screening and assessment tools will be utilized 

20 to place participants in the treatment alter21 native to incarceration program. 

22 ‘‘(d) REQUIREMENTS.—Each eligible entity awarded 

23 a grant for a treatment alternative to incarceration pro24 gram under this section shall— 

mstockstill on DSK4VPTVN1PROD with BILLS

27 

•S 524 RS

1 ‘‘(1) determine the terms and conditions of par2 ticipation in the program by eligible participants, 

3 taking into consideration the collateral consequences 

4 of an arrest, prosecution, or criminal conviction; 

5 ‘‘(2) ensure that each substance abuse and 

6 mental health treatment component is licensed and 

7 qualified by the relevant jurisdiction; 

8 ‘‘(3) for programs described in subsection 

9 (b)(2), organize an enforcement unit comprised of 

10 appropriately trained law enforcement professionals 

11 under the supervision of the State, tribal, or local 

12 criminal justice agency involved, the duties of which 

13 shall include— 

14 ‘‘(A) the verification of addresses and 

15 other contacts of each eligible participant who 

16 participates or desires to participate in the pro17 gram; and 

18 ‘‘(B) if necessary, the location, apprehen19 sion, arrest, and return to court of an eligible 

20 participant in the program who has absconded 

21 from the facility of a treatment provider or has 

22 otherwise violated the terms and conditions of 

23 the program, consistent with Federal and State 

24 confidentiality requirements; 

mstockstill on DSK4VPTVN1PROD with BILLS

28 

•S 524 RS

1 ‘‘(4) notify the relevant criminal justice entity if 

2 any eligible participant in the program absconds 

3 from the facility of the treatment provider or other4 wise violates the terms and conditions of the pro5 gram, consistent with Federal and State confiden6 tiality requirements; 

7 ‘‘(5) submit periodic reports on the progress of 

8 treatment or other measured outcomes from partici9 pation in the program of each eligible offender par10 ticipating in the program to the relevant State, trib11 al, or local criminal justice agency; 

12 ‘‘(6) describe the evidence-based methodology 

13 and outcome measurements that will be used to 

14 evaluate the program, and specifically explain how 

15 such measurements will provide valid measures of 

16 the impact of the program; and 

17 ‘‘(7) describe how the program could be broadly 

18 replicated if demonstrated to be effective. 

19 ‘‘(e) USE OF FUNDS.—An eligible entity shall use a 

20 grant received under this section for expenses of a treat21 ment alternative to incarceration program, including— 

22 ‘‘(1) salaries, personnel costs, equipment costs, 

23 and other costs directly related to the operation of 

24 the program, including the enforcement unit; 

mstockstill on DSK4VPTVN1PROD with BILLS

29 

•S 524 RS

1 ‘‘(2) payments for treatment providers that are 

2 approved by the relevant State or tribal jurisdiction 

3 and licensed, if necessary, to provide needed treat4 ment to eligible offenders participating in the pro5 gram, including medication assisted treatment, 

6 aftercare supervision, vocational training, education, 

7 and job placement; and 

8 ‘‘(3) payments to public and nonprofit private 

9 entities that are approved by the State or tribal ju10 risdiction and licensed, if necessary, to provide alco11 hol and drug addiction treatment and mental health 

12 treatment to eligible offenders participating in the 

13 program. 

14 ‘‘(f) SUPPLEMENT NOT SUPPLANT.—An eligible enti15 ty shall use Federal funds received under this section only 

16 to supplement the funds that would, in the absence of 

17 those Federal funds, be made available from other Federal 

18 and non-Federal sources for the activities described in this 

19 section, and not to supplant those funds. 

20 ‘‘(g) GEOGRAPHIC DISTRIBUTION.—The Attorney 

21 General shall ensure that, to the extent practicable, the 

22 geographical distribution of grants under this section is 

23 equitable and includes a grant to an eligible entity in— 

24 ‘‘(1) each State; 

25 ‘‘(2) rural, suburban, and urban areas; and 

mstockstill on DSK4VPTVN1PROD with BILLS

30 

•S 524 RS

1 ‘‘(3) tribal jurisdictions. 

2 ‘‘(h) PRIORITY CONSIDERATION WITH RESPECT TO

3 STATES.—In awarding grants to States under this sec4 tion, the Attorney General shall give priority to a State 

5 that provides civil liability protection for first responders, 

6 health professionals, and family members administering 

7 naloxone to counteract opioid overdoses by— 

8 ‘‘(1) enacting legislation that provides such civil 

9 liability protection; or 

10 ‘‘(2) providing a certification by the attorney 

11 general of the State that the attorney general has— 

12 ‘‘(A) reviewed any applicable civil liability 

13 protection law to determine the applicability of 

14 the law with respect to first responders, health 

15 care professionals, family members, and other 

16 individuals who may administer naloxone to in17 dividuals reasonably believed to be suffering 

18 from opioid overdose; and 

19 ‘‘(B) concluded that the law described in 

20 subparagraph (A) provides adequate civil liabil21 ity protection applicable to such persons. 

22 ‘‘(i) REPORTS AND EVALUATIONS.— 

23 ‘‘(1) IN GENERAL.—Each fiscal year, each re24 cipient of a grant under this section during that fis25 cal year shall submit to the Attorney General a remstockstill on DSK4VPTVN1PROD with BILLS

31 

•S 524 RS

1 port on the outcomes of activities carried out using 

2 that grant in such form, containing such informa3 tion, and on such dates as the Attorney General 

4 shall specify. 

5 ‘‘(2) CONTENTS.—A report submitted under 

6 paragraph (1) shall— 

7 ‘‘(A) describe best practices for treatment 

8 alternatives; and 

9 ‘‘(B) identify training requirements for law 

10 enforcement officers who participate in treat11 ment alternative to incarceration programs. 

12 ‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There 

13 are authorized to be appropriated to carry out this section 

14 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

15 SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND 

16 IMPLEMENTATION DEMONSTRATION. 

17 Part MM of the Omnibus Crime Control and Safe 

18 Streets Act of 1968, as amended by section 201, is amend19 ed by adding at the end the following: 

20 ‘‘SEC. 3035. LAW ENFORCEMENT NALOXONE TRAINING AND 

21 IMPLEMENTATION DEMONSTRATION. 

22 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

23 entity’ means a State, local, or tribal law enforcement 

24 agency. 

mstockstill on DSK4VPTVN1PROD with BILLS

32 

•S 524 RS

1 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen2 eral, in coordination with the Secretary of Health and 

3 Human Services and the Director of the Office of National 

4 Drug Control Policy, may make grants to eligible entities 

5 to create a demonstration law enforcement program to 

6 prevent opioid and heroin overdose death. 

7 ‘‘(c) APPLICATION.— 

8 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

9 grant under this section shall submit an application 

10 to the Attorney General— 

11 ‘‘(A) that meets the criteria under para12 graph (2); and 

13 ‘‘(B) at such time, in such manner, and 

14 accompanied by such information as the Attor15 ney General may require. 

16 ‘‘(2) CRITERIA.—An eligible entity, in submit17 ting an application under paragraph (1), shall— 

18 ‘‘(A) describe the evidence-based method19 ology and outcome measurements that will be 

20 used to evaluate the program funded with a 

21 grant under this section, and specifically ex22 plain how such measurements will provide valid 

23 measures of the impact of the program; 

mstockstill on DSK4VPTVN1PROD with BILLS

33 

•S 524 RS

1 ‘‘(B) describe how the program could be 

2 broadly replicated if demonstrated to be effec3 tive; 

4 ‘‘(C) identify the governmental and com5 munity agencies that the program will coordi6 nate; and 

7 ‘‘(D) describe how law enforcement agen8 cies will coordinate with their corresponding 

9 State substance abuse and mental health agen10 cies to identify protocols and resources that are 

11 available to victims and families, including in12 formation on treatment and recovery resources. 

13 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

14 grant received under this section to— 

15 ‘‘(1) make naloxone available to be carried and 

16 administered by law enforcement officers; 

17 ‘‘(2) train and provide resources for law en18 forcement officers on carrying and administering 

19 naloxone for the prevention of opioid and heroin 

20 overdose death; and 

21 ‘‘(3) establish processes, protocols, and mecha22 nisms for referral to treatment. 

23 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

mstockstill on DSK4VPTVN1PROD with BILLS

34 

•S 524 RS

1 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen2 eral may not award a grant under this section in an 

3 amount that exceeds $500,000. 

4 ‘‘(2) DURATION.—The Attorney General shall 

5 award grants under this section for a period not to 

6 exceed 2 years. 

7 ‘‘(f) TECHNICAL ASSISTANCE GRANTS.—The Attor8 ney General shall make a grant for the purpose of pro9 viding technical assistance and training on the use of 

10 naloxone to reverse overdose deaths and mechanisms for 

11 referral to treatment for an eligible entity receiving a 

12 grant under this section. 

13 ‘‘(g) EVALUATION.—The Attorney General shall con14 duct an evaluation of grants made under this section to 

15 determine— 

16 ‘‘(1) the number of officers equipped with 

17 naloxone for the prevention of fatal opioid and her18 oin overdose; 

19 ‘‘(2) the number of opioid and heroin overdoses 

20 reversed by officers receiving training and supplies 

21 of naloxone through a grant received under this sec22 tion; 

23 ‘‘(3) the number of calls for service related to 

24 opioid and heroin overdose; 

mstockstill on DSK4VPTVN1PROD with BILLS

35 

•S 524 RS

1 ‘‘(4) the extent to which overdose victims and 

2 families receive information about treatment services 

3 and available data describing treatment admissions; 

4 and 

5 ‘‘(5) the research, training, and naloxone supply 

6 needs of law enforcement and first responder agen7 cies, including those agencies that are not receiving 

8 grants under this section. 

9 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

10 are authorized to be appropriated to carry out this section 

11 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

12 SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

13 Part MM of the Omnibus Crime Control and Safe 

14 Streets Act of 1968, as amended by section 202, is amend15 ed by adding at the end the following: 

16 ‘‘SEC. 3036. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

17 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

18 entity’ means— 

19 ‘‘(1) a State, local, or tribal law enforcement 

20 agency; 

21 ‘‘(2) a manufacturer, distributor, or reverse dis22 tributor of prescription medications; 

23 ‘‘(3) a retail pharmacy; 

24 ‘‘(4) a registered narcotic treatment program; 

mstockstill on DSK4VPTVN1PROD with BILLS

36 

•S 524 RS

1 ‘‘(5) a hospital or clinic with an on-site phar2 macy; 

3 ‘‘(6) an eligible long-term care facility; or 

4 ‘‘(7) any other entity authorized by the Drug 

5 Enforcement Administration to dispose of prescrip6 tion medications. 

7 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen8 eral, in coordination with the Administrator of the Drug 

9 Enforcement Administration, the Secretary of Health and 

10 Human Services, and the Director of the Office of Na11 tional Drug Control Policy, may make grants to eligible 

12 entities to expand or make available disposal sites for un13 wanted prescription medications. 

14 ‘‘(c) APPLICATION.— 

15 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

16 grant under this section shall submit an application 

17 to the Attorney General— 

18 ‘‘(A) that meets the criteria under para19 graph (2); and 

20 ‘‘(B) at such time, in such manner, and 

21 accompanied by such information as the Attor22 ney General may require. 

23 ‘‘(2) CRITERIA.—An eligible entity, in submit24 ting an application under paragraph (1), shall— 

mstockstill on DSK4VPTVN1PROD with BILLS

37 

•S 524 RS

1 ‘‘(A) describe the evidence-based method2 ology and outcome measurements that will be 

3 used to evaluate the program funded with a 

4 grant under this section, and specifically ex5 plain how such measurements will provide valid 

6 measures of the impact of the program; 

7 ‘‘(B) describe how the program could be 

8 broadly replicated if demonstrated to be effec9 tive; and 

10 ‘‘(C) identify the governmental and com11 munity agencies that will coordinate the pro12 gram. 

13 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

14 grant received under this section for— 

15 ‘‘(1) expenses of a prescription drug disposal 

16 site, including materials and resources; 

17 ‘‘(2) implementing disposal procedures and 

18 processes; 

19 ‘‘(3) implementing community education strate20 gies, including community education materials and 

21 resources; 

22 ‘‘(4) replicating a prescription drug take back 

23 initiative throughout multiple jurisdictions; and 

24 ‘‘(5) training of law enforcement officers and 

25 other community participants. 

mstockstill on DSK4VPTVN1PROD with BILLS

38 

•S 524 RS

1 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

2 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen3 eral may not award a grant under this section in an 

4 amount that exceeds $250,000. 

5 ‘‘(2) DURATION.—The Attorney General shall 

6 award grants under this section for a period not to 

7 exceed 2 years. 

8 ‘‘(f) TECHNICAL ASSISTANCE GRANT.—The Attorney 

9 General shall make a grant to a national nonprofit organi10 zation to provide technical assistance and training for an 

11 eligible entity receiving a grant under this section. 

12 ‘‘(g) EVALUATION.— 

13 ‘‘(1) IN GENERAL.—The Attorney General shall 

14 make a grant for evaluation of the performance of 

15 each eligible entity receiving a grant under this sec16 tion. 

17 ‘‘(2) REPORTS.—Each fiscal year, the recipient 

18 of a grant under this subsection shall submit to the 

19 Attorney General a report that evaluates— 

20 ‘‘(A) the effectiveness of the prescription 

21 drug take back program of each eligible entity 

22 receiving a grant under this section; and 

23 ‘‘(B) the effect of disposal efforts on drug 

24 circulation. 

mstockstill on DSK4VPTVN1PROD with BILLS

39 

•S 524 RS

1 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $2,500,000 for each of fiscal years 2016 through 2020.’’. 

4 TITLE III—TREATMENT AND 

5 RECOVERY 

6 SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT7 MENT AND INTERVENTIONS DEMONSTRA8 TION. 

9 Subpart 1 of part B of title V of the Public Health 

10 Service Act (42 U.S.C. 290bb et seq.) is amended— 

11 (1) by redesignating section 514 (42 U.S.C. 

12 290bb–9), as added by section 3632 of the Meth13 amphetamine Anti-Proliferation Act of 2000 (Public 

14 Law 106–310; 114 Stat. 1236), as section 514B; 

15 and 

16 (2) by adding at the end the following: 

17 ‘‘SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREAT18 MENT AND INTERVENTIONS DEMONSTRA19 TION. 

20 ‘‘(a) GRANTS.— 

21 ‘‘(1) AUTHORITY TO MAKE GRANTS.—The Di22 rector of the Center for Substance Abuse Treatment 

23 (referred to in this section as the ‘Director’) may 

24 award grants to State substance abuse agencies, 

25 units of local government, nonprofit organizations, 

mstockstill on DSK4VPTVN1PROD with BILLS

40 

•S 524 RS

1 and Indian tribes or tribal organizations (as defined 

2 in section 4 of the Indian Health Care Improvement 

3 Act (25 U.S.C. 1603)) that have a high rate, or 

4 have had a rapid increase, in the use of heroin or 

5 other opioids, in order to permit such entities to ex6 pand activities, including an expansion in the avail7 ability of medication assisted treatment, with respect 

8 to the treatment of addiction in the specific geo9 graphical areas of such entities where there is a rate 

10 or rapid increase in the use of heroin or other 

11 opioids. 

12 ‘‘(2) RECIPIENTS.—The entities receiving 

13 grants under paragraph (1) shall be selected by the 

14 Director. 

15 ‘‘(3) NATURE OF ACTIVITIES.—The grant funds 

16 awarded under paragraph (1) shall be used for ac17 tivities that are based on reliable scientific evidence 

18 of efficacy in the treatment of problems related to 

19 heroin or other opioids. 

20 ‘‘(b) GEOGRAPHIC DISTRIBUTION.—The Director 

21 shall ensure that grants awarded under subsection (a) are 

22 distributed equitably among the various regions of the Na23 tion and among rural, urban, and suburban areas that are 

24 affected by the use of heroin or other opioids. 

25 ‘‘(c) ADDITIONAL ACTIVITIES.—The Director shall— 

mstockstill on DSK4VPTVN1PROD with BILLS

41 

•S 524 RS

1 ‘‘(1) evaluate the activities supported by grants 

2 awarded under subsection (a); 

3 ‘‘(2) disseminate widely such significant infor4 mation derived from the evaluation as the Director 

5 considers appropriate; 

6 ‘‘(3) provide States, Indian tribes and tribal or7 ganizations, and providers with technical assistance 

8 in connection with the provision of treatment of 

9 problems related to heroin and other opioids; and 

10 ‘‘(4) fund only those applications that specifi11 cally support recovery services as a critical compo12 nent of the grant program. 

13 ‘‘(d) DEFINITION.—The term ‘medication assisted 

14 treatment’ means the use, for problems relating to heroin 

15 and other opioids, of medications approved by the Food 

16 and Drug Administration in combination with counseling 

17 and behavioral therapies. 

18 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.— 

19 ‘‘(1) IN GENERAL.—There are authorized to be 

20 appropriated to carry out this section $12,000,000 

21 for fiscal year 2016 and such sums as may be nec22 essary for each of fiscal years 2016 through 2020. 

23 ‘‘(2) USE OF CERTAIN FUNDS.—Of the funds 

24 appropriated to carry out this section in any fiscal 

25 year, the lesser of 5 percent of such funds or 

mstockstill on DSK4VPTVN1PROD with BILLS

42 

•S 524 RS

1 $1,000,000 shall be available to the Director for 

2 purposes of carrying out subsection (c).’’. 

3 SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED 

4 TREATMENT AND INTERVENTIONS DEM5 ONSTRATION. 

6 Part MM of the Omnibus Crime Control and Safe 

7 Streets Act of 1968, as amended by section 203, is amend8 ed by adding at the end the following: 

9 ‘‘SEC. 3037. CRIMINAL JUSTICE MEDICATION ASSISTED 

10 TREATMENT AND INTERVENTIONS DEM11 ONSTRATION. 

12 ‘‘(a) DEFINITIONS.—In this section— 

13 ‘‘(1) the term ‘criminal justice agency’ means a 

14 State, local, or tribal— 

15 ‘‘(A) court; 

16 ‘‘(B) prison; 

17 ‘‘(C) jail; or 

18 ‘‘(D) other agency that performs the ad19 ministration of criminal justice, including pros20 ecution, pretrial services, and community super21 vision; and 

22 ‘‘(2) the term ‘eligible entity’ means a State, 

23 unit of local government, or Indian tribe. 

24 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen25 eral, in coordination with the Secretary of Health and 

mstockstill on DSK4VPTVN1PROD with BILLS

43 

•S 524 RS

1 Human Services and the Director of the Office of National 

2 Drug Control Policy, may make grants to eligible entities 

3 to implement medication assisted treatment programs 

4 through criminal justice agencies. 

5 ‘‘(c) APPLICATION.— 

6 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

7 grant under this section shall submit an application 

8 to the Attorney General— 

9 ‘‘(A) that meets the criteria under para10 graph (2); and 

11 ‘‘(B) at such time, in such manner, and 

12 accompanied by such information as the Attor13 ney General may require. 

14 ‘‘(2) CRITERIA.—An eligible entity, in submit15 ting an application under paragraph (1), shall— 

16 ‘‘(A) certify that each medication assisted 

17 treatment program funded with a grant under 

18 this section has been developed in consultation 

19 with the Single State Authority for Substance 

20 Abuse; and 

21 ‘‘(B) describe how data will be collected 

22 and analyzed to determine the effectiveness of 

23 the program described in subparagraph (A). 

24 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

25 grant received under this section for expenses of— 

mstockstill on DSK4VPTVN1PROD with BILLS

44 

•S 524 RS

1 ‘‘(1) a medication assisted treatment program, 

2 including the expenses of prescribing medications 

3 recognized by the Food and Drug Administration for 

4 opioid treatment in conjunction with psychological 

5 and behavioral therapy; 

6 ‘‘(2) training criminal justice agency personnel 

7 and treatment providers on medication assisted 

8 treatment; 

9 ‘‘(3) cross-training personnel providing behav10 ioral health and health services, administration of 

11 medicines, and other administrative expenses, includ12 ing required reports; and 

13 ‘‘(4) the provision of recovery coaches who are 

14 responsible for providing mentorship and transition 

15 plans to individuals reentering society following in16 carceration or alternatives to incarceration. 

17 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

18 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen19 eral may not award a grant under this section in an 

20 amount that exceeds $750,000. 

21 ‘‘(2) DURATION.—The Attorney General shall 

22 award grants under this section for a period not to 

23 exceed 2 years. 

24 ‘‘(f) PRIORITY CONSIDERATION WITH RESPECT TO

25 STATES.—In awarding grants to States under this secmstockstill on DSK4VPTVN1PROD with BILLS

45 

•S 524 RS

1 tion, the Attorney General shall give priority to a State 

2 that provides civil liability protection for first responders, 

3 health professionals, and family members administering 

4 naloxone to counteract opioid overdoses by— 

5 ‘‘(1) enacting legislation that provides such civil 

6 liability protection; or 

7 ‘‘(2) providing a certification by the attorney 

8 general of the State that the attorney general has— 

9 ‘‘(A) reviewed any applicable civil liability 

10 protection law to determine the applicability of 

11 the law with respect to first responders, health 

12 care professionals, family members, and other 

13 individuals who may administer naloxone to in14 dividuals reasonably believed to be suffering 

15 from opioid overdose; and 

16 ‘‘(B) concluded that the law described in 

17 subparagraph (A) provides adequate civil liabil18 ity protection applicable to such persons. 

19 ‘‘(g) TECHNICAL ASSISTANCE.—The Attorney Gen20 eral, in coordination with the Director of the National In21 stitute on Drug Abuse and the Secretary of Health and 

22 Human Services, shall provide technical assistance and 

23 training for an eligible entity receiving a grant under this 

24 section. 

25 ‘‘(h) REPORTS.— 

mstockstill on DSK4VPTVN1PROD with BILLS

46 

•S 524 RS

1 ‘‘(1) IN GENERAL.—An eligible entity receiving 

2 a grant under this subsection shall submit a report 

3 to the Attorney General on the outcomes of each 

4 grant received under this section for individuals re5 ceiving medication assisted treatment, based on— 

6 ‘‘(A) the recidivism of the individuals; 

7 ‘‘(B) the treatment outcomes of the indi8 viduals, including maintaining abstinence from 

9 illegal, unauthorized, and unprescribed or 

10 undispensed opioids and heroin; 

11 ‘‘(C) a comparison of the cost of providing 

12 medication assisted treatment to the cost of in13 carceration or other participation in the crimi14 nal justice system; 

15 ‘‘(D) the housing status of the individuals; 

16 and 

17 ‘‘(E) the employment status of the individ18 uals. 

19 ‘‘(2) CONTENTS AND TIMING.—Each report de20 scribed in paragraph (1) shall be submitted annually 

21 in such form, containing such information, and on 

22 such dates as the Attorney General shall specify. 

23 ‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 

24 are authorized to be appropriated to carry out this section 

25 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

mstockstill on DSK4VPTVN1PROD with BILLS

47 

•S 524 RS

1 SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE. 

2 (a) DEFINITIONS.—In this section: 

3 (1) ELIGIBLE ENTITY.—The term ‘‘eligible enti4 ty’’ means— 

5 (A) a high school that has been accredited 

6 as a recovery high school by the Association of 

7 Recovery Schools; 

8 (B) an accredited high school that is seek9 ing to establish or expand recovery support 

10 services; 

11 (C) an institution of higher education; 

12 (D) a recovery program at a nonprofit col13 legiate institution; or 

14 (E) a nonprofit organization. 

15 (2) INSTITUTION OF HIGHER EDUCATION.—The 

16 term ‘‘institution of higher education’’ has the 

17 meaning given the term in section 101 of the Higher 

18 Education Act of 1965 (20 U.S.C. 1001). 

19 (3) RECOVERY PROGRAM.—The term ‘‘recovery 

20 program’’— 

21 (A) means a program to help individuals 

22 who are recovering from substance use dis23 orders to initiate, stabilize, and maintain 

24 healthy and productive lives in the community; 

25 and 

mstockstill on DSK4VPTVN1PROD with BILLS

48 

•S 524 RS

1 (B) includes peer-to-peer support and com2 munal activities to build recovery skills and 

3 supportive social networks. 

4 (b) GRANTS AUTHORIZED.—The ONDCP Recovery 

5 Branch, in consultation with the Secretary of Education, 

6 may award grants to eligible entities to enable the entities 

7 to— 

8 (1) provide substance use recovery support serv9 ices to young people in high school and enrolled in 

10 institutions of higher education; 

11 (2) help build communities of support for young 

12 people in recovery through a spectrum of activities 

13 such as counseling and healthy and wellness-oriented 

14 social activities; and 

15 (3) encourage initiatives designed to help young 

16 people achieve and sustain recovery from substance 

17 use disorders. 

18 (c) USE OF FUNDS.—Grants awarded under sub19 section (b) may be used for activities to develop, support, 

20 and maintain youth recovery support services, including— 

21 (1) the development and maintenance of a dedi22 cated physical space for recovery programs; 

23 (2) dedicated staff for the provision of recovery 

24 programs; 

mstockstill on DSK4VPTVN1PROD with BILLS

49 

•S 524 RS

1 (3) healthy and wellness-oriented social activi2 ties and community engagement; 

3 (4) establishment of recovery high schools; 

4 (5) coordination of recovery programs with— 

5 (A) substance use disorder treatment pro6 grams and systems; 

7 (B) providers of mental health services; 

8 (C) primary care providers; 

9 (D) the criminal justice system, including 

10 the juvenile justice system; 

11 (E) employers; 

12 (F) housing services; 

13 (G) child welfare services; 

14 (H) institutions of secondary higher edu15 cation and institutions of higher education; and 

16 (I) other programs or services related to 

17 the welfare of an individual in recovery from a 

18 substance use disorder; 

19 (6) the development of peer-to-peer support 

20 programs or services; and 

21 (7) additional activities that help youths and 

22 young adults to achieve recovery from substance use 

23 disorders. 

mstockstill on DSK4VPTVN1PROD with BILLS

50 

•S 524 RS

1 (d) RESOURCE CENTER.—The ONDCP Recovery 

2 Branch shall establish a resource center to provide tech3 nical support to recipients of grants under this section. 

4 (e) AUTHORIZATION OF APPROPRIATIONS.—There 

5 are authorized to be appropriated to carry out this section 

6 $3,000,000 for fiscal year 2016 and each of the 5 suc7 ceeding fiscal years. 

8 SEC. 304. BUILDING COMMUNITIES OF RECOVERY. 

9 (a) DEFINITION.—In this section, the term ‘‘recovery 

10 community organization’’ means an independent nonprofit 

11 organization that— 

12 (1) mobilizes resources within and outside of 

13 the recovery community to increase the prevalence 

14 and quality of long-term recovery from substance 

15 use disorders; and 

16 (2) is wholly or principally governed by people 

17 in recovery for substance use disorders who reflect 

18 the community served. 

19 (b) GRANTS AUTHORIZED.—The ONDCP Recovery 

20 Branch, in consultation with the Substance Abuse and 

21 Mental Health Services Administration, may award grants 

22 to recovery community organizations to enable such orga23 nizations to develop, expand, and enhance recovery serv24 ices. 

mstockstill on DSK4VPTVN1PROD with BILLS

51 

•S 524 RS

1 (c) MAXIMUM GRANT AMOUNT.—The ONDCP Re2 covery Branch may not award a grant under this section 

3 in an amount that exceeds $200,000. 

4 (d) FEDERAL SHARE.—The Federal share of the 

5 costs of a program funded by a grant under this section 

6 may not exceed 50 percent. 

7 (e) USE OF FUNDS.—Grants awarded under sub8 section (b)— 

9 (1) shall be used to develop, expand, and en10 hance community and statewide recovery support 

11 services; and 

12 (2) may be used to— 

13 (A) advocate for individuals in recovery 

14 from substance use disorders; 

15 (B) build connections between recovery 

16 networks, between recovery community organi17 zations, and with other recovery support serv18 ices, including— 

19 (i) substance use disorder treatment 

20 programs and systems; 

21 (ii) providers of mental health serv22 ices; 

23 (iii) primary care providers; 

24 (iv) the criminal justice system; 

25 (v) employers; 

mstockstill on DSK4VPTVN1PROD with BILLS

52 

•S 524 RS

1 (vi) housing services; 

2 (vii) child welfare agencies; and 

3 (viii) other recovery support services 

4 that facilitate recovery from substance use 

5 disorders; 

6 (C) reduce the stigma associated with sub7 stance use disorders; 

8 (D) conduct public education and outreach 

9 on issues relating to substance use disorders 

10 and recovery, including— 

11 (i) how to identify the signs of addic12 tion; 

13 (ii) the resources that are available 

14 for individuals struggling with addiction; 

15 (iii) the resources that are available to 

16 help support individuals in recovery; and 

17 (iv) information on the medical con18 sequences of substance use disorders, in19 cluding neonatal abstinence syndrome and 

20 potential infection with human immuno21 deficiency virus and viral hepatitis; and 

22 (E) carry out other activities that 

23 strengthen the network of community support 

24 for individuals in recovery. 

mstockstill on DSK4VPTVN1PROD with BILLS

53 

•S 524 RS

1 (f) RESOURCE CENTER.—The ONDCP Recovery 

2 Branch shall establish a resource center to provide tech3 nical assistance to recipients of grants under this section 

4 and to provide information to individuals seeking to sup5 port people in recovery from substance use disorders. 

6 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

7 are authorized to be appropriated to carry out this section 

8 $5,700,000 in fiscal year 2016 and each of the 3 suc9 ceeding fiscal years. 

10 TITLE IV—ADDRESSING 

11 COLLATERAL CONSEQUENCES 

12 SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION 

13 GRANT PROGRAM. 

14 Title I of the Omnibus Crime Control and Safe 

15 Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amend16 ed— 

17 (1) by redesignating part KK as part LL; 

18 (2) by redesignating sections 3011 and 3012 as 

19 sections 3021 and 3022, respectively; and 

20 (3) by inserting before part LL, as redesig21 nated, the following: 

mstockstill on DSK4VPTVN1PROD with BILLS

54 

•S 524 RS

1 ‘‘PART KK—CORRECTIONAL EDUCATION 

2 DEMONSTRATION GRANT PROGRAM 

3 ‘‘SEC. 3011. CORRECTIONAL EDUCATION DEMONSTRATION 

4 GRANT PROGRAM. 

5 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

6 entity’ means a State, unit of local government, nonprofit 

7 organization, or Indian tribe. 

8 ‘‘(b) GRANT PROGRAM AUTHORIZED.—The Attorney 

9 General may make grants of not more than $750,000 to 

10 eligible entities to design, implement, and expand edu11 cational programs for offenders in prisons, jails, and juve12 nile facilities, including to pay for— 

13 ‘‘(1) basic education, secondary level academic 

14 education, high school equivalency examination prep15 aration, career technical education, and English as 

16 a second language instruction at the basic, sec17 ondary, or post-secondary levels, for adult and juve18 nile populations; 

19 ‘‘(2) screening and assessment of inmates to as20 sess education level, needs, occupational interest or 

21 aptitude, risk level, and other needs, and case man22 agement services; 

23 ‘‘(3) hiring and training of instructors and 

24 aides, reimbursement of non-corrections staff and 

25 experts, reimbursement of stipends paid to inmate 

mstockstill on DSK4VPTVN1PROD with BILLS

55 

•S 524 RS

1 tutors or aides, and the costs of training inmate tu2 tors and aides; 

3 ‘‘(4) instructional supplies and equipment, in4 cluding occupational program supplies and equip5 ment to the extent that the supplies and equipment 

6 are used for instructional purposes; 

7 ‘‘(5) partnerships and agreements with commu8 nity colleges, universities, and career technology edu9 cation program providers, including tuition pay10 ments; 

11 ‘‘(6) certification programs providing recognized 

12 high school equivalency certificates and industry rec13 ognized credentials; and 

14 ‘‘(7) technology solutions to— 

15 ‘‘(A) meet the instructional, assessment, 

16 and information needs of correctional popu17 lations; and 

18 ‘‘(B) facilitate the continued participation 

19 of incarcerated students in community-based 

20 education programs after the students are re21 leased from incarceration. 

22 ‘‘(c) APPLICATION.—An eligible entity desiring a 

23 grant under this section shall submit to the Attorney Gen24 eral an application in such form and manner, at such time, 

mstockstill on DSK4VPTVN1PROD with BILLS

56 

•S 524 RS

1 and accompanied by such information as the Attorney 

2 General specifies. 

3 ‘‘(d) PRIORITY CONSIDERATIONS.—In awarding 

4 grants under this section, the Attorney General shall give 

5 priority to applicants that— 

6 ‘‘(1) assess the level of risk and need of in7 mates, including by— 

8 ‘‘(A) assessing the need for English as a 

9 second language instruction; 

10 ‘‘(B) conducting educational assessments; 

11 and 

12 ‘‘(C) assessing occupational interests and 

13 aptitudes; 

14 ‘‘(2) target educational services to assessed 

15 needs, including academic and occupational at the 

16 basic, secondary, or post-secondary level; 

17 ‘‘(3) target career technology education pro18 grams to— 

19 ‘‘(A) areas of identified occupational de20 mand; and 

21 ‘‘(B) employment opportunities in the com22 munities in which students are reasonably ex23 pected to reside post-release; 

mstockstill on DSK4VPTVN1PROD with BILLS

57 

•S 524 RS

1 ‘‘(4) include a range of appropriate educational 

2 opportunities at the basic, secondary, and post-sec3 ondary levels; 

4 ‘‘(5) include opportunities for students to attain 

5 industry recognized credentials; 

6 ‘‘(6) include partnership or articulation agree7 ments linking institutional education programs with 

8 community sited programs provided by adult edu9 cation program providers and accredited institutions 

10 of higher education, community colleges, and voca11 tional training institutions; and 

12 ‘‘(7) explicitly include career pathways models 

13 offering opportunities for incarcerated students to 

14 develop academic skills, in-demand occupational 

15 skills and credentials, occupational experience in in16 stitutional work programs or work release programs, 

17 and linkages with employers in the community, so 

18 that incarcerated students have opportunities to em19 bark on careers with strong prospects for both post20 release employment and advancement in a career 

21 ladder over time. 

22 ‘‘(e) REQUIREMENTS.—An eligible entity desiring a 

23 grant under this section shall— 

24 ‘‘(1) describe the evidence-based methodology 

25 and outcome measurements that will be used to 

mstockstill on DSK4VPTVN1PROD with BILLS

58 

•S 524 RS

1 evaluate each program funded with a grant under 

2 this section, and specifically explain how such meas3 urements will provide valid measures of the impact 

4 of the program; and 

5 ‘‘(2) describe how the program described in 

6 paragraph (1) could be broadly replicated if dem7 onstrated to be effective. 

8 ‘‘(f) CONTROL OF INTERNET ACCESS.—An entity 

9 that receives a grant under this section shall restrict ac10 cess to the Internet by prisoners, as appropriate, to ensure 

11 public safety. 

12 ‘‘SEC. 3012. AUTHORIZATION OF APPROPRIATIONS. 

13 ‘‘There are authorized to be appropriated $5,000,000 

14 to carry out this part for fiscal years 2016 through 

15 2020.’’. 

16 SEC. 402. REVISION OF FAFSA FORM. 

17 Section 483 of the Higher Education Act of 1965 (20 

18 U.S.C. 1090) is amended by adding at the end the fol19 lowing: 

20 ‘‘(i) CONVICTIONS.—The Secretary shall not include 

21 any question about the conviction of an applicant for the 

22 possession or sale of illegal drugs on the FAFSA (or any 

23 other form developed under subsection (a)).’’. 

mstockstill on DSK4VPTVN1PROD with BILLS

59 

•S 524 RS

1 SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COL2 LATERAL CONSEQUENCES. 

3 (a) DEFINITION.—In this section, the term ‘‘collat4 eral consequence’’ means a penalty, disability, or dis5 advantage— 

6 (1) imposed on an individual as a result of a 

7 criminal conviction but not as part of the judgment 

8 of the court that imposes the conviction; or 

9 (2) that an administrative agency, official, or 

10 civil court is authorized, but not required, to impose 

11 on an individual convicted of a felony, misdemeanor, 

12 or other criminal offense. 

13 (b) ESTABLISHMENT.— 

14 (1) IN GENERAL.—Not later than 30 days after 

15 the date of enactment of this Act, the Secretary of 

16 Health and Human Services (in this section referred 

17 to as the ‘‘Secretary’’) shall establish a bipartisan 

18 task force to be known as the Task Force on Recov19 ery and Collateral Consequences (in this section re20 ferred to as the ‘‘Task Force’’). 

21 (2) MEMBERSHIP.— 

22 (A) TOTAL NUMBER OF MEMBERS.—The 

23 Task Force shall include 10 members, who shall 

24 be appointed by the Secretary in accordance 

25 with subparagraphs (B) and (C). 

mstockstill on DSK4VPTVN1PROD with BILLS

60 

•S 524 RS

1 (B) MEMBERS OF THE TASK FORCE.—The 

2 Task Force shall include— 

3 (i) members who have national rec4 ognition and significant expertise in areas 

5 such as health care, housing, employment, 

6 substance use disorder, mental health, law 

7 enforcement, and law; 

8 (ii) not fewer than 2 members— 

9 (I) who have personally experi10 enced substance abuse or addiction 

11 and are in recovery; and 

12 (II) not fewer than 1 one of 

13 whom has benefited from medication 

14 assisted treatment; and 

15 (iii) to the extent practicable, mem16 bers who formerly served as elected offi17 cials at the State and Federal levels. 

18 (C) TIMING.—The Secretary shall appoint 

19 the members of the Task Force not later than 

20 60 days after the date on which the Task Force 

21 is established under paragraph (1). 

22 (3) CHAIRPERSON.—The Task Force shall se23 lect a chairperson or co-chairpersons from among 

24 the members of the Task Force. 

25 (c) DUTIES OF THE TASK FORCE.— 

mstockstill on DSK4VPTVN1PROD with BILLS

61 

•S 524 RS

1 (1) IN GENERAL.—The Task Force shall— 

2 (A) identify collateral consequences for in3 dividuals with Federal or State drug convictions 

4 who are in recovery for substance use disorder; 

5 and 

6 (B) determine whether the collateral con7 sequences identified under subparagraph (A) 

8 unnecessarily delay individuals in recovery from 

9 resuming their personal and professional activi10 ties. 

11 (2) RECOMMENDATIONS.—Not later than 180 

12 days after the date of the first meeting of the Task 

13 Force, the Task Force shall develop recommenda14 tions for proposed legislative and regulatory changes 

15 to reduce and, to the extent practicable, eliminate 

16 the collateral consequences identified by the Task 

17 Force under paragraph (1). 

18 (3) COLLECTION OF INFORMATION.—The Task 

19 Force shall hold hearings, require the testimony and 

20 attendance of witnesses, and secure information 

21 from any department or agency of the United States 

22 in performing the duties under paragraphs (1) and 

23 (2). 

24 (4) REPORT.—Not later than 1 year after the 

25 date of the first meeting of the Task Force, the 

mstockstill on DSK4VPTVN1PROD with BILLS

62 

•S 524 RS

1 Task Force shall submit a report detailing the find2 ings and recommendations of the Task Force to— 

3 (A) each relevant committee of Congress; 

4 (B) the head of each relevant department 

5 or agency of the United States; 

6 (C) the President; and 

7 (D) the Vice President. 

8 TITLE V—ADDICTION AND 

9 TREATMENT SERVICES FOR 

10 WOMEN, FAMILIES, AND VET11 ERANS 

12 SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO 

13 ADDRESS OPIOID AND HEROIN ABUSE BY 

14 PREGNANT AND PARENTING FEMALE OF15 FENDERS. 

16 Part MM of the Omnibus Crime Control and Safe 

17 Streets Act of 1968, as amended by section 302, is amend18 ed by adding at the end the following: 

19 ‘‘SEC. 3038. AUTHORITY TO AWARD COMPETITIVE GRANTS 

20 TO ADDRESS OPIOID AND HEROIN ABUSE BY 

21 PREGNANT AND PARENTING FEMALE OF22 FENDERS. 

23 ‘‘(a) DEFINITIONS.—In this section— 

24 ‘‘(1) the term ‘State criminal justice agency’ 

25 means the agency of the State responsible for admstockstill on DSK4VPTVN1PROD with BILLS

63 

•S 524 RS

1 ministering criminal justice funds, including the Ed2 ward Byrne Memorial Justice Assistance Grant Pro3 gram under subpart 1 of part E; and 

4 ‘‘(2) the term ‘State substance abuse agency’ 

5 means the agency of the State responsible for the 

6 State prevention, treatment, and recovery system, 

7 including management of the Substance Abuse Pre8 vention and Treatment Block Grant under subpart 

9 II of part B of title XIX of the Public Health Serv10 ice Act (42 U.S.C. 300x–21 et seq.). 

11 ‘‘(b) PURPOSE AND PROGRAM AUTHORITY.— 

12 ‘‘(1) GRANT AUTHORIZATION.—The Attorney 

13 General, in coordination with the Secretary of 

14 Health and Human Services, may award competitive 

15 grants jointly to a State substance abuse agency and 

16 a State criminal justice agency to address the use of 

17 opioids and heroin among pregnant and parenting 

18 female offenders in the State to promote public safe19 ty, public health, family permanence, and well-being. 

20 ‘‘(2) PURPOSES AND PROGRAM AUTHORITY.—A 

21 grant under this section shall be used to facilitate or 

22 enhance collaboration between the State criminal 

23 justice and State substance abuse systems in order 

24 to carry out programs to address the use of opioid 

mstockstill on DSK4VPTVN1PROD with BILLS

64 

•S 524 RS

1 and heroin abuse by pregnant and parenting female 

2 offenders. 

3 ‘‘(c) APPLICATIONS.— 

4 ‘‘(1) IN GENERAL.—A State substance abuse 

5 agency and State criminal justice agency desiring a 

6 grant under this section shall jointly submit to the 

7 Attorney General an application in such form, and 

8 containing such information, as the Attorney Gen9 eral may prescribe by regulation or guidelines. 

10 ‘‘(2) CONTENTS.— 

11 ‘‘(A) IN GENERAL.—Each application for a 

12 grant under this section shall contain a plan to 

13 expand the services of the State for pregnant 

14 and parenting female offenders for the use of 

15 opioids, heroin, and other drugs, which shall be 

16 in accordance with regulations or guidelines es17 tablished by the Attorney General, in consulta18 tion with the Secretary of Health and Human 

19 Services. 

20 ‘‘(B) PLAN.—A plan submitted under sub21 paragraph (A) shall, at a minimum, include— 

22 ‘‘(i) a description of how the appli23 cants will work jointly to address the needs 

24 associated with the use of opioids or heroin 

25 by pregnant and parenting female offendmstockstill on DSK4VPTVN1PROD with BILLS

65 

•S 524 RS

1 ers to promote family stability and perma2 nence; 

3 ‘‘(ii) a description of the nature and 

4 the extent of the problem of opioid and 

5 heroin use by pregnant and parenting fe6 male offenders in the State; 

7 ‘‘(iii) a certification that the State has 

8 involved counties and other units of local 

9 government, when appropriate, in the de10 velopment, expansion, modification, oper11 ation, or improvement of proposed pro12 grams to address the problems associated 

13 with opioid and heroin use; 

14 ‘‘(iv) a certification that funds re15 ceived under this section will be used to 

16 supplement, not supplant, other Federal, 

17 State, and local funds; and 

18 ‘‘(v) a description of clinically appro19 priate practices and procedures to— 

20 ‘‘(I) screen and assess pregnant 

21 and parenting female offenders for 

22 problems associated with opioids and 

23 heroin; 

24 ‘‘(II) screen and assess pregnant 

25 and parenting female offenders demmstockstill on DSK4VPTVN1PROD with BILLS

66 

•S 524 RS

1 onstrating problems associated with 

2 opioids and heroin for co-occurring 

3 mental disorders; 

4 ‘‘(III) provide clinically appro5 priate services, including medication 

6 assisted treatment, for female offend7 ers and their children in the same lo8 cation to promote family permanence 

9 and self-sufficiency; and 

10 ‘‘(IV) provide for a process to en11 hance or ensure the abilities of the 

12 State criminal justice agency and 

13 State substance abuse agency to work 

14 together to reunite families when ap15 propriate in the case where family 

16 treatment is not provided. 

17 ‘‘(d) PERIOD OF GRANT; RENEWAL.— 

18 ‘‘(1) PERIOD.—A grant under this section shall 

19 be for a period of 3 years. 

20 ‘‘(2) RENEWAL.—A State substance abuse 

21 agency and a State criminal justice agency receiving 

22 a grant under this section may apply for and, after 

23 the end of the period of the first grant under this 

24 section, receive 1 additional grant under this section. 

25 ‘‘(e) PERFORMANCE ACCOUNTABILITY; REPORTS.— 

mstockstill on DSK4VPTVN1PROD with BILLS

67 

•S 524 RS

1 ‘‘(1) REPORTS.—A State substance abuse agen2 cy and a State criminal justice agency receiving a 

3 grant under this section shall jointly submit to the 

4 Attorney General a report on the activities carried 

5 out under the grant at the end of each fiscal year 

6 during the period of the grant. 

7 ‘‘(2) EVALUATION.—Not later than 1 year after 

8 the end of the period of a grant under this section, 

9 the Attorney General shall submit a report to each 

10 committee of Congress with jurisdiction of the pro11 gram under this section that summarizes the reports 

12 of the recipients of the grant and provides rec13 ommendations, if any, for further legislative action. 

14 ‘‘(f) TRAINING AND TECHNICAL ASSISTANCE.—The 

15 Attorney General shall support State substance abuse and 

16 State criminal justice agencies by developing, in consulta17 tion with State substance abuse and State criminal justice 

18 agencies, and offering a program of training and technical 

19 assistance to assist the agencies in developing programs 

20 and protocols— 

21 ‘‘(1) to implement this section; and 

22 ‘‘(2) for effectively working across the Federal 

23 and State criminal and substance abuse systems. 

mstockstill on DSK4VPTVN1PROD with BILLS

68 

•S 524 RS

1 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

4 SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE 

5 TREATMENT. 

6 Section 2925 of the Omnibus Crime Control and Safe 

7 Streets Act of 1968 (42 U.S.C. 3797s–4) is amended— 

8 (1) by striking ‘‘An entity’’ and inserting ‘‘(a) 

9 ENTITY REPORTS.—An entity’’; and 

10 (2) by adding at the end the following: 

11 ‘‘(b) ATTORNEY GENERAL REPORT ON FAMILY12 BASED SUBSTANCE ABUSE TREATMENT.—The Attorney 

13 General shall submit to Congress an annual report that 

14 describes the number of grants awarded under section 

15 2921(1) and how such grants are used by the recipients 

16 for family-based substance abuse treatment programs that 

17 serve as alternatives to incarceration for custodial parents 

18 to receive treatment and services as a family.’’. 

19 SEC. 503. VETERANS’ TREATMENT COURTS. 

20 Section 2991 of the Omnibus Crime Control and Safe 

21 Streets Act of 1968 (42 U.S.C. 3797aa) is amended— 

22 (1) by redesignating subsection (i) as subsection 

23 (j); 

24 (2) by inserting after subsection (h) the fol25 lowing: 

mstockstill on DSK4VPTVN1PROD with BILLS

69 

•S 524 RS

1 ‘‘(i) ASSISTING VETERANS.— 

2 ‘‘(1) DEFINITIONS.—In this subsection: 

3 ‘‘(A) PEER TO PEER SERVICES OR PRO4 GRAMS.—The term ‘peer to peer services or 

5 programs’ means services or programs that con6 nect qualified veterans with other veterans for 

7 the purpose of providing support and 

8 mentorship to assist qualified veterans in ob9 taining treatment, recovery, stabilization, or re10 habilitation. 

11 ‘‘(B) QUALIFIED VETERAN.—The term 

12 ‘qualified veteran’ means a preliminarily quali13 fied offender who— 

14 ‘‘(i) has served on active duty in any 

15 branch of the Armed Forces, including the 

16 National Guard and reserve components; 

17 and 

18 ‘‘(ii)(I) was discharged or released 

19 from such service under conditions other 

20 than dishonorable; or 

21 ‘‘(II) was discharged or released from 

22 such service under dishonorable conditions, 

23 if the reason for that discharge or release, 

24 if known, is attributable to drug use. 

mstockstill on DSK4VPTVN1PROD with BILLS

70 

•S 524 RS

1 ‘‘(C) VETERANS TREATMENT COURT PRO2 GRAM.—The term ‘veterans treatment court 

3 program’ means a court program involving col4 laboration among criminal justice, veterans, and 

5 mental health and substance abuse agencies 

6 that provides qualified veterans with— 

7 ‘‘(i) intensive judicial supervision and 

8 case management, which may include ran9 dom and frequent drug testing where ap10 propriate; 

11 ‘‘(ii) a full continuum of treatment 

12 services, including mental health services, 

13 substance abuse services, medical services, 

14 and services to address trauma; 

15 ‘‘(iii) alternatives to incarceration; 

16 and 

17 ‘‘(iv) other appropriate services, in18 cluding housing, transportation, mentoring, 

19 employment, job training, education, and 

20 assistance in applying for and obtaining 

21 available benefits. 

22 ‘‘(2) VETERANS ASSISTANCE PROGRAM.— 

23 ‘‘(A) IN GENERAL.—The Attorney General, 

24 in consultation with the Secretary of Veterans 

mstockstill on DSK4VPTVN1PROD with BILLS

71 

•S 524 RS

1 Affairs, may award grants under this sub2 section to applicants to establish or expand— 

3 ‘‘(i) veterans treatment court pro4 grams; 

5 ‘‘(ii) peer to peer services or programs 

6 for qualified veterans; 

7 ‘‘(iii) practices that identify and pro8 vide treatment, rehabilitation, legal, transi9 tional, and other appropriate services to 

10 qualified veterans who have been incarcer11 ated; and 

12 ‘‘(iv) training programs to teach 

13 criminal justice, law enforcement, correc14 tions, mental health, and substance abuse 

15 personnel how to identify and appro16 priately respond to incidents involving 

17 qualified veterans. 

18 ‘‘(B) PRIORITY.—In awarding grants 

19 under this subsection, the Attorney General 

20 shall give priority to applications that— 

21 ‘‘(i) demonstrate collaboration be22 tween and joint investments by criminal 

23 justice, mental health, substance abuse, 

24 and veterans service agencies; 

mstockstill on DSK4VPTVN1PROD with BILLS

72 

•S 524 RS

1 ‘‘(ii) promote effective strategies to 

2 identify and reduce the risk of harm to 

3 qualified veterans and public safety; and 

4 ‘‘(iii) propose interventions with em5 pirical support to improve outcomes for 

6 qualified veterans.’’; and 

7 (3) in subsection (j), as so redesignated— 

8 (A) by redesignating paragraph (2) as 

9 paragraph (3); and 

10 (B) by inserting after paragraph (1) the 

11 following: 

12 ‘‘(2) VETERANS TREATMENT COURTS.—In addi13 tion to the amounts authorized under paragraph (1), 

14 there are authorized to be appropriated to the Attor15 ney General $5,000,000 for each of fiscal years 

16 2016 through 2020 to carry out subsection (i).’’. 

17 TITLE VI—INCENTIVIZING STATE 

18 COMPREHENSIVE INITIA19 TIVES TO ADDRESS OPIOID 

20 AND HEROIN ABUSE 

21 SEC. 601. STATE DEMONSTRATION GRANTS FOR COM22 PREHENSIVE OPIOID ABUSE RESPONSE. 

23 Part MM of the Omnibus Crime Control and Safe 

24 Streets Act of 1968, as amended by section 501, is amend25 ed by adding at the end the following: 

mstockstill on DSK4VPTVN1PROD with BILLS

73 

•S 524 RS

1 ‘‘SEC. 3039. STATE DEMONSTRATION GRANTS FOR COM2 PREHENSIVE OPIOID ABUSE RESPONSE. 

3 ‘‘(a) DEFINITIONS.—In this section— 

4 ‘‘(1) the term ‘dispenser’ has the meaning given 

5 the term in section 102 of the Controlled Substances 

6 Act (21 U.S.C. 802); 

7 ‘‘(2) the term ‘prescriber of a schedule II, III, 

8 or IV controlled substance’ does not include a pre9 scriber of a schedule II, III, or IV controlled sub10 stance that dispenses the substance— 

11 ‘‘(A) for use on the premises on which the 

12 substance is dispensed; 

13 ‘‘(B) in a hospital emergency room, when 

14 the substance is in short supply; 

15 ‘‘(C) for a certified opioid treatment pro16 gram; or 

17 ‘‘(D) in other situations as the Attorney 

18 General may reasonably determine; 

19 ‘‘(3) the term ‘prescriber’ means a dispenser 

20 who prescribes a controlled substance, or the agent 

21 of such a dispenser; and 

22 ‘‘(4) the term ‘schedule II, III, or IV controlled 

23 substance’ means a controlled substance that is list24 ed on schedule II, schedule III, or schedule IV of 

25 section 202(c) of the Controlled Substances Act (21 

26 U.S.C. 812(c)). 

mstockstill on DSK4VPTVN1PROD with BILLS

74 

•S 524 RS

1 ‘‘(b) PLANNING AND IMPLEMENTATION GRANTS.— 

2 ‘‘(1) IN GENERAL.—The Attorney General, in 

3 coordination with the Secretary of Health and 

4 Human Services and the Director of the Office of 

5 National Drug Control Policy, may award grants to 

6 States, and combinations thereof, to prepare a com7 prehensive plan for and implement an integrated 

8 opioid abuse response initiative. 

9 ‘‘(2) PURPOSES.—A State receiving a grant 

10 under this section shall establish a comprehensive 

11 response to opioid abuse, which shall include— 

12 ‘‘(A) prevention and education efforts 

13 around heroin and opioid use, treatment, and 

14 recovery; 

15 ‘‘(B) a comprehensive prescription drug 

16 monitoring program to track dispensing of 

17 schedule II, III, or IV controlled substances, 

18 which shall include— 

19 ‘‘(i) data sharing with other States by 

20 statute, regulation, or interstate agree21 ment; and 

22 ‘‘(ii) educating physicians, residents, 

23 medical students, and other prescribers of 

24 Schedule II, III, or IV controlled submstockstill on DSK4VPTVN1PROD with BILLS

75 

•S 524 RS

1 stances on the prescription drug moni2 toring program of the State; 

3 ‘‘(C) developing, implementing, or expand4 ing the prescription drug and opioid addiction 

5 treatment program of the State by— 

6 ‘‘(i) expanding programs for medica7 tion assisted treatment of prescription 

8 drug and opioid addiction, including train9 ing for treatment and recovery support 

10 providers; 

11 ‘‘(ii) developing, implementing, or ex12 panding programs for behavioral health 

13 therapy for individuals who are in treat14 ment for prescription drug and opioid ad15 diction, including contingency manage16 ment, cognitive behavioral therapy, and 

17 motivational enhancements; 

18 ‘‘(iii) developing, implementing, or ex19 panding programs to screen individuals 

20 who are in treatment for prescription drug 

21 and opioid addiction for hepatitis C and 

22 HIV, and provide treatment for those indi23 viduals if clinically appropriate; or 

24 ‘‘(iv) developing, implementing, or ex25 panding programs that provide screening, 

mstockstill on DSK4VPTVN1PROD with BILLS

76 

•S 524 RS

1 early intervention, and referral to treat2 ment (commonly referred to as ‘SBIRT’) 

3 to teenagers and young adults in primary 

4 care, middle schools, high schools, univer5 sities, school-based health centers, and 

6 other community-based health care settings 

7 frequently accessed by teenagers or young 

8 adults; and 

9 ‘‘(D) developing, implementing, and ex10 panding programs to prevent overdose death of 

11 prescription medications and opioids. 

12 ‘‘(3) PLANNING GRANT APPLICATIONS.— 

13 ‘‘(A) APPLICATION.— 

14 ‘‘(i) IN GENERAL.—A State desiring a 

15 planning grant under this section to pre16 pare a comprehensive plan for an inte17 grated opioid abuse response initiative 

18 shall submit to the Attorney General an 

19 application in such form, and containing 

20 such information, as the Attorney General 

21 may prescribe by regulation or guidelines. 

22 ‘‘(ii) REQUIREMENTS.—An application 

23 for a planning grant under this section 

24 shall, at a minimum, include— 

mstockstill on DSK4VPTVN1PROD with BILLS

77 

•S 524 RS

1 ‘‘(I) a budget and a budget jus2 tification for the activities to be car3 ried out using the grant; 

4 ‘‘(II) a description of the activi5 ties proposed to be carried out using 

6 the grant, including a schedule for 

7 completion of such activities; 

8 ‘‘(III) outcome measures that will 

9 be used to measure the effectiveness 

10 of the programs and initiatives to ad11 dress opioids; and 

12 ‘‘(IV) a description of the per13 sonnel necessary to complete such ac14 tivities. 

15 ‘‘(B) PERIOD; NONRENEWABILITY.—A 

16 planning grant under this section shall be for a 

17 period of 1 year. A State may not receive more 

18 than 1 planning grant under this section. 

19 ‘‘(C) AMOUNT.—A planning grant under 

20 this section may not exceed $100,000, except 

21 that the Attorney General may, for good cause, 

22 approve a grant in a higher amount. 

23 ‘‘(D) STRATEGIC PLAN AND PROGRAM IM24 PLEMENTATION PLAN.—A State receiving a 

25 planning grant under this section shall develop 

mstockstill on DSK4VPTVN1PROD with BILLS

78 

•S 524 RS

1 a strategic plan and a program implementation 

2 plan. 

3 ‘‘(4) IMPLEMENTATION GRANTS.— 

4 ‘‘(A) APPLICATION.—A State desiring an 

5 implementation grant under this section to im6 plement a comprehensive strategy for address7 ing opioid abuse shall submit to the Attorney 

8 General an application in such form, and con9 taining such information, as the Attorney Gen10 eral may prescribe by regulation or guidelines. 

11 ‘‘(B) USE OF FUNDS.—A State that re12 ceives an implementation grant under this sec13 tion shall use the grant for the cost of carrying 

14 out an integrated opioid abuse response pro15 gram in accordance with this section, including 

16 for technical assistance, training, and adminis17 trative expenses. 

18 ‘‘(C) REQUIREMENTS.—An integrated 

19 opioid abuse response program carried out 

20 using an implementation grant under this sec21 tion shall— 

22 ‘‘(i) ensure that each prescriber of a 

23 schedule II, III, or IV controlled substance 

24 in the State— 

mstockstill on DSK4VPTVN1PROD with BILLS

79 

•S 524 RS

1 ‘‘(I) registers with the prescrip2 tion drug monitoring program of the 

3 State; and 

4 ‘‘(II) consults the prescription 

5 drug monitoring program database of 

6 the State before prescribing a sched7 ule II, III, or IV controlled substance; 

8 ‘‘(ii) ensure that each dispenser of a 

9 schedule II, III, or IV controlled substance 

10 in the State— 

11 ‘‘(I) registers with the prescrip12 tion drug monitoring program of the 

13 State; 

14 ‘‘(II) consults the prescription 

15 drug monitoring program database of 

16 the State before dispensing a schedule 

17 II, III, or IV controlled substance; 

18 and 

19 ‘‘(III) reports to the prescription 

20 drug monitoring program of the 

21 State, at a minimum, each instance in 

22 which a schedule II, III, or IV con23 trolled substance is dispensed, with 

24 limited exceptions, as defined by the 

25 State, which shall indicate the premstockstill on DSK4VPTVN1PROD with BILLS

80 

•S 524 RS

1 scriber by name and National Pro2 vider Identifier; 

3 ‘‘(iii) require that, not fewer than 4 

4 times each year, the State agency or agen5 cies that administer the prescription drug 

6 monitoring program of the State prepare 

7 and provide to each prescriber of a sched8 ule II, III, or IV controlled substance an 

9 informational report that shows how the 

10 prescribing patterns of the prescriber com11 pare to prescribing practices of the peers 

12 of the prescriber and expected norms; 

13 ‘‘(iv) if informational reports provided 

14 to a prescriber under clause (iii) indicate 

15 that the prescriber is repeatedly falling 

16 outside of expected norms or standard 

17 practices for the prescriber’s field, direct 

18 the prescriber to educational resources on 

19 appropriate prescribing of controlled sub20 stances; 

21 ‘‘(v) ensure that the prescriber licens22 ing board of the State receives a report de23 scribing any prescribers that repeatedly 

24 fall outside of expected norms or standard 

mstockstill on DSK4VPTVN1PROD with BILLS

81 

•S 524 RS

1 practices for the prescriber’s field, as de2 scribed in clause (iii); 

3 ‘‘(vi) require consultation with the 

4 Single State Authority for Substance 

5 Abuse; and 

6 ‘‘(vii) establish requirements for how 

7 data will be collected and analyzed to de8 termine the effectiveness of the program. 

9 ‘‘(D) PERIOD.—An implementation grant 

10 under this section shall be for a period of 2 

11 years. 

12 ‘‘(E) AMOUNT.—The amount of an imple13 mentation grant under this section may not ex14 ceed $5,000,000 except that the Attorney Gen15 eral may, for good cause, approve a grant in a 

16 higher amount. 

17 ‘‘(5) PRIORITY CONSIDERATIONS.—In awarding 

18 planning and implementation grants under this sec19 tion, the Attorney General shall give priority to a 

20 State that— 

21 ‘‘(A) provides civil liability protection for 

22 first responders, health professionals, and fam23 ily members administering naloxone to counter24 act opioid overdoses by— 

mstockstill on DSK4VPTVN1PROD with BILLS

82 

•S 524 RS

1 ‘‘(i) enacting legislation that provides 

2 such civil liability protection; or 

3 ‘‘(ii) providing a certification by the 

4 attorney general of the State that the at5 torney general has— 

6 ‘‘(I) reviewed any applicable civil 

7 liability protection law to determine 

8 the applicability of the law with re9 spect to first responders, health care 

10 professionals, family members, and 

11 other individuals who may administer 

12 naloxone to individuals reasonably be13 lieved to be suffering from opioid 

14 overdose; and 

15 ‘‘(II) concluded that the law de16 scribed in subclause (I) provides ade17 quate civil liability protection applica18 ble to such persons; 

19 ‘‘(B) have in effect legislation or imple20 ment a policy under which the State shall not 

21 terminate, but may suspend, enrollment under 

22 the State plan for medical assistance under title 

23 XIX of the Social Security Act (42 U.S.C. 1396 

24 et seq.) for an individual who is incarcerated for 

25 a period of fewer than 2 years; 

mstockstill on DSK4VPTVN1PROD with BILLS

83 

•S 524 RS

1 ‘‘(C) have a process for enrollment in serv2 ices and benefits necessary by criminal justice 

3 agencies to initiate or continue treatment in the 

4 community, under which an individual who is 

5 incarcerated may, while incarcerated, enroll in 

6 services and benefits that are necessary for the 

7 individual to continue treatment upon release 

8 from incarceration; 

9 ‘‘(D) ensures the capability of data sharing 

10 with other States, such as by making data 

11 available to a prescription monitoring hub; 

12 ‘‘(E) ensures that data recorded in the 

13 prescription drug monitoring program database 

14 of the State is available within 24 hours, to the 

15 extent possible; and 

16 ‘‘(F) ensures that the prescription drug 

17 monitoring program of the State notifies pre18 scribers and dispensers of schedule II, III, or 

19 IV controlled substances when overuse or mis20 use of such controlled substances by patients is 

21 suspected. 

22 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 

23 are authorized to be appropriated to carry out this section 

24 $15,000,000 for each of fiscal years 2016 through 2020.’’. 

mstockstill on DSK4VPTVN1PROD with BILLS

84 

•S 524 RS

1 TITLE VII—OFFSET; GAO 

2 REPORT 

3 SEC. 701. OFFSET. 

4 It is the sense of Congress that the amounts ex5 pended to carry out this Act and the amendments made 

6 by this Act should be offset by a corresponding reduction 

7 in Federal non-defense discretionary spending. 

8 SEC. 702. GAO REPORT ON IMD EXCLUSION. 

9 (a) DEFINITION.—In this section, the term ‘‘Med10 icaid Institutions for Mental Disease exclusion’’ means the 

11 prohibition on Federal matching payments under Medicaid 

12 for patients who have attained age 22, but have not at13 tained age 65, in an institution for mental diseases under 

14 subparagraph (B) of the matter following subsection (a) 

15 of section 1905 of the Social Security Act and subsection 

16 (i) of such section (42 U.S.C. 1396d). 

17 (b) REPORT REQUIRED.—Not later than 180 days 

18 after the date of enactment of this Act, the Comptroller 

19 General of the United States shall submit to Congress a 

20 report on the impact that the Medicaid Institutions for 

21 Mental Disease exclusion has on access to treatment for 

22 individuals with a substance use disorder. 

23 (c) ELEMENTS.—The report required under sub24 section (b) shall include the following: 

mstockstill on DSK4VPTVN1PROD with BILLS

85 

•S 524 RS

1 (1) An analysis of whether the following policy 

2 changes to the Medicaid Institutions for Mental Dis3 ease exclusion would enhance access to treatment for 

4 individuals with a substance use disorder: 

5 (A) Removing substance use disorder 

6 treatment and facilities from the Medicaid In7 stitutions for Mental Disease exclusion. 

8 (B) Amending section 1905(i) of the Social 

9 Security Act (42 U.S.C. 1396d(i)) to modestly 

10 raise the 16-bed limit in the definition of an in11 stitution for mental diseases under that section. 

12 (C) Repealing the Medicaid Institutions for 

13 Mental Disease exclusion. 

14 (2) An analysis of whether and to what extent 

15 the quality of care for substance use disorder treat16 ment is impacted by the Medicaid Institutions for 

17 Mental Disease exclusion. 

18 (3) An analysis of barriers in accessing State19 specific information related to the impact of the 

20 Medicaid Institutions for Mental Disease exclusion 

21 on access to treatment. 

22 (4) An analysis of the difference in cost be23 tween treatment for a substance use disorder in a 

24 hospital setting compared to a community-based 

25 care setting. 

mstockstill on DSK4VPTVN1PROD with BILLS

86 

•S 524 RS

1 (5) An analysis of the characteristics of institu2 tions for mental diseases (as defined in section 

3 1905(i) of the Social Security Act (42 U.S.C. 

4 1396d(i))), including the patient capacity of such in5 stitutions as well as the type of care setting, among 

6 other characteristics. 

7 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

8 (a) SHORT TITLE.—This Act may be cited as the 

9 ‘‘Comprehensive Addiction and Recovery Act of 2016’’. 

10 (b) TABLE OF CONTENTS.—The table of contents for 

11 this Act is as follows: 

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 

Sec. 3. Definitions. 

TITLE I—PREVENTION AND EDUCATION 

Sec. 101. Development of best practices for the use of prescription opioids. 

Sec. 102. Awareness campaigns. 

Sec. 103. Community-based coalition enhancement grants to address local drug 

crises. 

TITLE II—LAW ENFORCEMENT AND TREATMENT 

Sec. 201. Treatment alternative to incarceration programs. 

Sec. 202. First responder training for the use of drugs and devices that rapidly 

reverse the effects of opioids. 

Sec. 203. Prescription drug take back expansion. 

Sec. 204. Heroin and methamphetamine task forces. 

TITLE III—TREATMENT AND RECOVERY 

Sec. 301. Evidence-based opioid and heroin treatment and interventions demonstration. 

Sec. 302. Criminal justice medication assisted treatment and interventions demonstration. 

Sec. 303. National youth recovery initiative. 

Sec. 304. Building communities of recovery. 

TITLE IV—ADDRESSING COLLATERAL CONSEQUENCES 

Sec. 401. Correctional education demonstration grant program. 

Sec. 402. National Task Force on Recovery and Collateral Consequences. 

mstockstill on DSK4VPTVN1PROD with BILLS

87 

•S 524 RS

TITLE V—ADDICTION AND TREATMENT SERVICES FOR WOMEN, 

FAMILIES, AND VETERANS 

Sec. 501. Improving treatment for pregnant and postpartum women. 

Sec. 502. Report on grants for family-based substance abuse treatment. 

Sec. 503. Veterans’ treatment courts. 

TITLE VI—INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO 

ADDRESS OPIOID AND HEROIN ABUSE 

Sec. 601. State demonstration grants for comprehensive opioid abuse response. 

TITLE VII—MISCELLANEOUS 

Sec. 701. GAO report on IMD exclusion. 

Sec. 702. Funding. 

Sec. 703. Conforming amendments. 

Sec. 704. Grant accountability. 

1 SEC. 2. FINDINGS. 

2 Congress finds the following: 

3 (1) The abuse of heroin and prescription opioid 

4 painkillers is having a devastating effect on public 

5 health and safety in communities across the United 

6 States. According to the Centers for Disease Control 

7 and Prevention, drug overdose deaths now surpass 

8 traffic crashes in the number of deaths caused by in9 jury in the United States. In 2014, an average of 

10 more than 120 people in the United States died from 

11 drug overdoses every day. 

12 (2) According to the National Institute on Drug 

13 Abuse (commonly known as ‘‘NIDA’’), the number of 

14 prescriptions for opioids increased from approxi15 mately 76,000,000 in 1991 to nearly 207,000,000 in 

16 2013, and the United States is the biggest consumer 

17 of opioids globally, accounting for almost 100 percent 

mstockstill on DSK4VPTVN1PROD with BILLS

88 

•S 524 RS

1 of the world total for hydrocodone and 81 percent for 

2 oxycodone. 

3 (3) Opioid pain relievers are the most widely 

4 misused or abused controlled prescription drugs (com5 monly referred to as ‘‘CPDs’’) and are involved in 

6 most CPD-related overdose incidents. According to the 

7 Drug Abuse Warning Network (commonly known as 

8 ‘‘DAWN’’), the estimated number of emergency de9 partment visits involving nonmedical use of prescrip10 tion opiates or opioids increased by 112 percent be11 tween 2006 and 2010, from 84,671 to 179,787. 

12 (4) The use of heroin in the United States has 

13 also spiked sharply in recent years. According to the 

14 most recent National Survey on Drug Use and 

15 Health, more than 900,000 people in the United 

16 States reported using heroin in 2014, nearly a 35 

17 percent increase from the previous year. Heroin over18 dose deaths more than tripled from 2010 to 2014. 

19 (5) The supply of cheap heroin available in the 

20 United States has increased dramatically as well, 

21 largely due to the activity of Mexican drug trafficking 

22 organizations. The Drug Enforcement Administration 

23 (commonly known as the ‘‘DEA’’) estimates that her24 oin seizures at the Mexican border have more than 

25 doubled since 2010, and heroin production in Mexico 

mstockstill on DSK4VPTVN1PROD with BILLS

89 

•S 524 RS

1 increased 62 percent from 2013 to 2014. While only 

2 8 percent of State and local law enforcement officials 

3 across the United States identified heroin as the 

4 greatest drug threat in their area in 2008, that num5 ber rose to 38 percent in 2015. 

6 (6) Law enforcement officials and treatment ex7 perts throughout the country report that many pre8 scription opioid users have turned to heroin as a 

9 cheaper or more easily obtained alternative to pre10 scription drugs. 

11 (7) According to a report by the National Asso12 ciation of State Alcohol and Drug Abuse Directors 

13 (commonly referred to as ‘‘NASADAD’’), 37 States re14 ported an increase in admissions to treatment for her15 oin use during the past 2 years, while admissions to 

16 treatment for prescription opiates increased 500 per17 cent from 2000 to 2012. 

18 (8) Research indicates that combating the opioid 

19 crisis, including abuse of prescription painkillers and, 

20 increasingly, heroin, requires a multi-pronged ap21 proach that involves prevention, education, moni22 toring, law enforcement initiatives, reducing drug di23 version and the supply of illicit drugs, expanding de24 livery of existing treatments (including medication 

25 assisted treatments), expanding access to overdose 

mstockstill on DSK4VPTVN1PROD with BILLS

90 

•S 524 RS

1 medications and interventions, and the development 

2 of new medications for pain that can augment the ex3 isting treatment arsenal. 

4 (9) Substance use disorders are a treatable dis5 ease. Discoveries in the science of addiction have led 

6 to advances in the treatment of substance use dis7 orders that help people stop abusing drugs and pre8 scription medications and resume their productive 

9 lives. 

10 (10) According to the National Survey on Drug 

11 Use and Health, approximately 22,700,000 people in 

12 the United States needed substance use disorder treat13 ment in 2013, but only 2,500,000 people received it. 

14 Furthermore, current treatment services are not ade15 quate to meet demand. According to a report commis16 sioned by the Substance Abuse and Mental Health 

17 Services Administration (commonly known as 

18 ‘‘SAMHSA’’), there are approximately 32 providers 

19 for every 1,000 individuals needing substance use dis20 order treatment. In some States, the ratio is much 

21 lower. 

22 (11) The overall cost of drug abuse, from health 

23 care- and criminal justice-related costs to lost produc24 tivity, is steep, totaling more than $700,000,000,000 

mstockstill on DSK4VPTVN1PROD with BILLS

91 

•S 524 RS

1 a year, according to NIDA. Effective substance abuse 

2 prevention can yield major economic dividends. 

3 (12) According to NIDA, when schools and com4 munities properly implement science-validated sub5 stance abuse prevention programs, abuse of alcohol, 

6 tobacco, and illicit drugs is reduced. Such programs 

7 help teachers, parents, and healthcare professionals 

8 shape the perceptions of youths about the risks of drug 

9 abuse. 

10 (13) Diverting certain individuals with sub11 stance use disorders from criminal justice systems 

12 into community-based treatment can save billions of 

13 dollars and prevent sizeable numbers of crimes, ar14 rests, and re-incarcerations over the course of those 

15 individuals’ lives. 

16 (14) According to the DEA, more than 2,700 

17 tons of expired, unwanted prescription medications 

18 have been collected since the enactment of the Secure 

19 and Responsible Drug Disposal Act of 2010 (Public 

20 Law 111–273; 124 Stat. 2858). 

21 (15) Faith-based, holistic, or drug-free models 

22 can provide a critical path to successful recovery for 

23 a great number of people in the United States. The 

24 2015 membership survey conducted by Alcoholics 

25 Anonymous (commonly known as ‘‘AA’’) found that 

mstockstill on DSK4VPTVN1PROD with BILLS

92 

•S 524 RS

1 73 percent of AA members were sober longer than 1 

2 year and attended 2.5 meetings per week. 

3 (16) Research shows that combining treatment 

4 medications with behavioral therapy is an effective 

5 way to facilitate success for some patients. Treatment 

6 approaches must be tailored to address the drug abuse 

7 patterns and drug-related medical, psychiatric, and 

8 social problems of each individual. Different types of 

9 medications may be useful at different stages of treat10 ment or recovery to help a patient stop using drugs, 

11 stay in treatment, and avoid relapse. Patients have a 

12 range of options regarding their path to recovery and 

13 many have also successfully addressed drug abuse 

14 through the use of faith-based, holistic, or drug-free 

15 models. 

16 (17) Individuals with mental illness, especially 

17 severe mental illness, are at considerably higher risk 

18 for substance abuse than the general population, and 

19 the presence of a mental illness complicates recovery 

20 from substance abuse. 

21 SEC. 3. DEFINITIONS. 

22 In this Act— 

23 (1) the term ‘‘medication assisted treatment’’ 

24 means the use, for problems relating to heroin and 

25 other opioids, of medications approved by the Food 

mstockstill on DSK4VPTVN1PROD with BILLS

93 

•S 524 RS

1 and Drug Administration in combination with coun2 seling and behavioral therapies; 

3 (2) the term ‘‘opioid’’ means any drug having an 

4 addiction-forming or addiction-sustaining liability 

5 similar to morphine or being capable of conversion 

6 into a drug having such addiction-forming or addic7 tion-sustaining liability; and 

8 (3) the term ‘‘State’’ means any State of the 

9 United States, the District of Columbia, the Common10 wealth of Puerto Rico, and any territory or possession 

11 of the United States. 

12 TITLE I—PREVENTION AND 

13 EDUCATION 

14 SEC. 101. DEVELOPMENT OF BEST PRACTICES FOR THE USE 

15 OF PRESCRIPTION OPIOIDS. 

16 (a) DEFINITIONS.—In this section— 

17 (1) the term ‘‘Secretary’’ means the Secretary of 

18 Health and Human Services; and 

19 (2) the term ‘‘task force’’ means the Pain Man20 agement Best Practices Inter-Agency Task Force con21 vened under subsection (b). 

22 (b) INTER-AGENCY TASK FORCE.—Not later than De23 cember 14, 2018, the Secretary, in cooperation with the Sec24 retary of Veterans Affairs, the Secretary of Defense, and the 

25 Administrator of the Drug Enforcement Administration, 

mstockstill on DSK4VPTVN1PROD with BILLS

94 

•S 524 RS

1 shall convene a Pain Management Best Practices Inter2 Agency Task Force to review, modify, and update, as ap3 propriate, best practices for pain management (including 

4 chronic and acute pain) and prescribing pain medication. 

5 (c) MEMBERSHIP.—The task force shall be comprised 

6 of— 

7 (1) representatives of— 

8 (A) the Department of Health and Human 

9 Services; 

10 (B) the Department of Veterans Affairs; 

11 (C) the Food and Drug Administration; 

12 (D) the Department of Defense; 

13 (E) the Drug Enforcement Administration; 

14 (F) the Centers for Disease Control and 

15 Prevention; 

16 (G) the National Academy of Medicine; 

17 (H) the National Institutes of Health; and 

18 (I) the Office of National Drug Control Pol19 icy; 

20 (2) physicians, dentists, and non-physician pre21 scribers; 

22 (3) pharmacists; 

23 (4) experts in the fields of pain research and ad24 diction research; 

25 (5) representatives of— 

mstockstill on DSK4VPTVN1PROD with BILLS

95 

•S 524 RS

1 (A) pain management professional organi2 zations; 

3 (B) the mental health treatment commu4 nity; 

5 (C) the addiction treatment community; 

6 (D) pain advocacy groups; and 

7 (E) groups with expertise around overdose 

8 reversal; and 

9 (6) other stakeholders, as the Secretary deter10 mines appropriate. 

11 (d) DUTIES.—The task force shall— 

12 (1) not later than 180 days after the date on 

13 which the task force is convened under subsection (b), 

14 review, modify, and update, as appropriate, best 

15 practices for pain management (including chronic 

16 and acute pain) and prescribing pain medication, 

17 taking into consideration— 

18 (A) existing pain management research; 

19 (B) recommendations from relevant con20 ferences; 

21 (C) ongoing efforts at the State and local 

22 levels and by medical professional organizations 

23 to develop improved pain management strategies, 

24 including consideration of alternatives to opioids 

mstockstill on DSK4VPTVN1PROD with BILLS

96 

•S 524 RS

1 to reduce opioid monotherapy in appropriate 

2 cases; 

3 (D) the management of high-risk popu4 lations, other than populations who suffer pain, 

5 who— 

6 (i) may use or be prescribed 

7 benzodiazepines, alcohol, and diverted 

8 opioids; or 

9 (ii) receive opioids in the course of 

10 medical care; and 

11 (E) the Proposed 2016 Guideline for Pre12 scribing Opioids for Chronic Pain issued by the 

13 Centers for Disease Control and Prevention (80 

14 Fed. Reg. 77351 (December 14, 2015)) and any 

15 final guidelines issued by the Centers for Disease 

16 Control and Prevention; 

17 (2) solicit and take into consideration public 

18 comment on the practices developed under paragraph 

19 (1), amending such best practices if appropriate; and 

20 (3) develop a strategy for disseminating informa21 tion about the best practices to stakeholders, as appro22 priate. 

23 (e) LIMITATION.—The task force shall not have rule24 making authority. 

mstockstill on DSK4VPTVN1PROD with BILLS

97 

•S 524 RS

1 (f) REPORT.—Not later than 270 days after the date 

2 on which the task force is convened under subsection (b), 

3 the task force shall submit to Congress a report that in4 cludes— 

5 (1) the strategy for disseminating best practices 

6 for pain management (including chronic and acute 

7 pain) and prescribing pain medication, as reviewed, 

8 modified, or updated under subsection (d); 

9 (2) the results of a feasibility study on linking 

10 the best practices described in paragraph (1) to re11 ceiving and renewing registrations under section 

12 303(f) of the Controlled Substances Act (21 U.S.C. 

13 823(f)); and 

14 (3) recommendations for effectively applying the 

15 best practices described in paragraph (1) to improve 

16 prescribing practices at medical facilities, including 

17 medical facilities of the Veterans Health Administra18 tion. 

19 SEC. 102. AWARENESS CAMPAIGNS. 

20 (a) IN GENERAL.—The Secretary of Health and 

21 Human Services, in coordination with the Attorney Gen22 eral, shall advance the education and awareness of the pub23 lic, providers, patients, and other appropriate entities re24 garding the risk of abuse of prescription opioid drugs if 

25 such products are not taken as prescribed. 

mstockstill on DSK4VPTVN1PROD with BILLS

98 

•S 524 RS

1 (b) DRUG-FREE MEDIA CAMPAIGN.— 

2 (1) IN GENERAL.—The Office of National Drug 

3 Control Policy, in coordination with the Secretary of 

4 Health and Human Services and the Attorney Gen5 eral, shall establish a national drug awareness cam6 paign. 

7 (2) REQUIREMENTS.—The national drug aware8 ness campaign required under paragraph (1) shall— 

9 (A) take into account the association be10 tween prescription opioid abuse and heroin use; 

11 (B) emphasize the similarities between her12 oin and prescription opioids and the effects of 

13 heroin and prescription opioids on the human 

14 body; and 

15 (C) bring greater public awareness to the 

16 dangerous effects of fentanyl when mixed with 

17 heroin or abused in a similar manner. 

18 SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 

19 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

20 Part II of title I of the Omnibus Crime Control and 

21 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.) is 

22 amended by striking section 2997 and inserting the fol23 lowing: 

mstockstill on DSK4VPTVN1PROD with BILLS

99 

•S 524 RS

1 ‘‘SEC. 2997. COMMUNITY-BASED COALITION ENHANCEMENT 

2 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

3 ‘‘(a) DEFINITIONS.—In this section— 

4 ‘‘(1) the term ‘Drug-Free Communities Act of 

5 1997’ means chapter 2 of the National Narcotics 

6 Leadership Act of 1988 (21 U.S.C. 1521 et seq.); 

7 ‘‘(2) the term ‘eligible entity’ means an organiza8 tion that— 

9 ‘‘(A) on or before the date of submitting an 

10 application for a grant under this section, re11 ceives or has received a grant under the Drug12 Free Communities Act of 1997; and 

13 ‘‘(B) has documented, using local data, 

14 rates of abuse of opioids or methamphetamines 

15 at levels that are— 

16 ‘‘(i) significantly higher than the na17 tional average as determined by the Attor18 ney General (including appropriate consid19 eration of the results of the Monitoring the 

20 Future Survey published by the National 

21 Institute on Drug Abuse and the National 

22 Survey on Drug Use and Health published 

23 by the Substance Abuse and Mental Health 

24 Services Administration); or 

25 ‘‘(ii) higher than the national average, 

26 as determined by the Attorney General (inmstockstill on DSK4VPTVN1PROD with BILLS

100 

•S 524 RS

1 cluding appropriate consideration of the re2 sults of the surveys described in clause (i)), 

3 over a sustained period of time; and 

4 ‘‘(3) the term ‘local drug crisis’ means, with re5 spect to the area served by an eligible entity— 

6 ‘‘(A) a sudden increase in the abuse of 

7 opioids or methamphetamines, as documented by 

8 local data; or 

9 ‘‘(B) the abuse of prescription medications, 

10 specifically opioids or methamphetamines, that 

11 is significantly higher than the national average, 

12 over a sustained period of time, as documented 

13 by local data. 

14 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney General, 

15 in coordination with the Director of the Office of National 

16 Drug Control Policy, may make grants to eligible entities 

17 to implement comprehensive community-wide strategies 

18 that address local drug crises within the area served by the 

19 eligible entity. 

20 ‘‘(c) APPLICATION.— 

21 ‘‘(1) IN GENERAL.—An eligible entity seeking a 

22 grant under this section shall submit an application 

23 to the Attorney General at such time, in such manner, 

24 and accompanied by such information as the Attor25 ney General may require. 

mstockstill on DSK4VPTVN1PROD with BILLS

101 

•S 524 RS

1 ‘‘(2) CRITERIA.—As part of an application for a 

2 grant under this section, the Attorney General shall 

3 require an eligible entity to submit a detailed, com4 prehensive, multi-sector plan for addressing the local 

5 drug crisis within the area served by the eligible enti6 ty. 

7 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

8 grant received under this section— 

9 ‘‘(1) for programs designed to implement com10 prehensive community-wide prevention strategies to 

11 address the local drug crisis in the area served by the 

12 eligible entity, in accordance with the plan submitted 

13 under subsection (c)(2); and 

14 ‘‘(2) to obtain specialized training and technical 

15 assistance from the organization funded under section 

16 4 of Public Law 107–82 (21 U.S.C. 1521 note). 

17 ‘‘(e) SUPPLEMENT NOT SUPPLANT.—An eligible entity 

18 shall use Federal funds received under this section only to 

19 supplement the funds that would, in the absence of those 

20 Federal funds, be made available from other Federal and 

21 non-Federal sources for the activities described in this sec22 tion, and not to supplant those funds. 

23 ‘‘(f) EVALUATION.—A grant under this section shall be 

24 subject to the same evaluation requirements and procedures 

25 as the evaluation requirements and procedures imposed on 

mstockstill on DSK4VPTVN1PROD with BILLS

102 

•S 524 RS

1 the recipient of a grant under the Drug-Free Communities 

2 Act of 1997. 

3 ‘‘(g) LIMITATION ON ADMINISTRATIVE EXPENSES.— 

4 Not more than 8 percent of the amounts made available 

5 pursuant to subsection (i) for a fiscal year may be used 

6 by the Attorney General to pay for administrative ex7 penses.’’. 

8 TITLE II—LAW ENFORCEMENT 

9 AND TREATMENT 

10 SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 

11 PROGRAMS. 

12 (a) DEFINITIONS.—In this section: 

13 (1) ELIGIBLE ENTITY.—The term ‘‘eligible enti14 ty’’ means a State, unit of local government, Indian 

15 tribe, or nonprofit organization. 

16 (2) ELIGIBLE PARTICIPANT.—The term ‘‘eligible 

17 participant’’ means an individual who— 

18 (A) comes into contact with the juvenile jus19 tice system or criminal justice system or is ar20 rested or charged with an offense that is not— 

21 (i) a crime of violence, as defined 

22 under applicable State law or section 16 of 

23 title 18, United States Code; or 

mstockstill on DSK4VPTVN1PROD with BILLS

103 

•S 524 RS

1 (ii) a serious drug offense, as defined 

2 under section 924(e)(2)(A) of title 18, 

3 United States Code; 

4 (B) has a current— 

5 (i) substance use disorder; or 

6 (ii) co-occurring mental illness and 

7 substance use disorder; and 

8 (C) has been approved for participation in 

9 a program funded under this section by, as ap10 plicable depending on the stage of the criminal 

11 justice process, the relevant law enforcement 

12 agency or prosecuting attorney, defense attorney, 

13 probation or corrections official, judge, or rep14 resentative from the relevant mental health or 

15 substance abuse agency. 

16 (b) PROGRAM AUTHORIZED.—The Secretary of Health 

17 and Human Services, in coordination with the Attorney 

18 General, may make grants to eligible entities to— 

19 (1) develop, implement, or expand a treatment 

20 alternative to incarceration program for eligible par21 ticipants, including— 

22 (A) pre-booking, including pre-arrest, treat23 ment alternative to incarceration programs, in24 cluding— 

mstockstill on DSK4VPTVN1PROD with BILLS

104 

•S 524 RS

1 (i) law enforcement training on sub2 stance use disorders and co-occurring men3 tal illness and substance use disorders; 

4 (ii) receiving centers as alternatives to 

5 incarceration of eligible participants; 

6 (iii) specialized response units for calls 

7 related to substance use disorders and co-oc8 curring mental illness and substance use 

9 disorders; and 

10 (iv) other pre-arrest or pre-booking 

11 treatment alternative to incarceration mod12 els; and 

13 (B) post-booking treatment alternative to 

14 incarceration programs, including— 

15 (i) specialized clinical case manage16 ment; 

17 (ii) pre-trial services related to sub18 stance use disorders and co-occurring men19 tal illness and substance use disorders; 

20 (iii) prosecutor and defender based 

21 programs; 

22 (iv) specialized probation; 

23 (v) programs utilizing the American 

24 Society of Addiction Medicine patient 

25 placement criteria; 

mstockstill on DSK4VPTVN1PROD with BILLS

105 

•S 524 RS

1 (vi) treatment and rehabilitation pro2 grams and recovery support services; and 

3 (vii) drug courts, DWI courts, and vet4 erans treatment courts; and 

5 (2) facilitate or enhance planning and collabora6 tion between State criminal justice systems and State 

7 substance abuse systems in order to more efficiently 

8 and effectively carry out programs described in para9 graph (1) that address problems related to the use of 

10 heroin and misuse of prescription drugs among eligi11 ble participants. 

12 (c) APPLICATION.— 

13 (1) IN GENERAL.—An eligible entity desiring a 

14 grant under this section shall submit an application 

15 to the Secretary of Health and Human Services— 

16 (A) that meets the criteria under paragraph 

17 (2); and 

18 (B) at such time, in such manner, and ac19 companied by such information as the Secretary 

20 of Health and Human Services may require. 

21 (2) CRITERIA.—An eligible entity, in submitting 

22 an application under paragraph (1), shall— 

23 (A) provide extensive evidence of collabora24 tion with State and local government agencies 

25 overseeing health, community corrections, courts, 

mstockstill on DSK4VPTVN1PROD with BILLS

106 

•S 524 RS

1 prosecution, substance abuse, mental health, vic2 tims services, and employment services, and with 

3 local law enforcement agencies; 

4 (B) demonstrate consultation with the Sin5 gle State Authority for Substance Abuse; 

6 (C) demonstrate consultation with the Sin7 gle State criminal justice planning agency; 

8 (D) demonstrate that evidence-based treat9 ment practices, including if applicable the use of 

10 medication assisted treatment, will be utilized; 

11 and 

12 (E) demonstrate that evidenced-based 

13 screening and assessment tools will be utilized to 

14 place participants in the treatment alternative 

15 to incarceration program. 

16 (d) REQUIREMENTS.—Each eligible entity awarded a 

17 grant for a treatment alternative to incarceration program 

18 under this section shall— 

19 (1) determine the terms and conditions of par20 ticipation in the program by eligible participants, 

21 taking into consideration the collateral consequences 

22 of an arrest, prosecution, or criminal conviction; 

23 (2) ensure that each substance abuse and mental 

24 health treatment component is licensed and qualified 

25 by the relevant jurisdiction; 

mstockstill on DSK4VPTVN1PROD with BILLS

107 

•S 524 RS

1 (3) for programs described in subsection (b)(2), 

2 organize an enforcement unit comprised of appro3 priately trained law enforcement professionals under 

4 the supervision of the State, tribal, or local criminal 

5 justice agency involved, the duties of which shall in6 clude— 

7 (A) the verification of addresses and other 

8 contacts of each eligible participant who partici9 pates or desires to participate in the program; 

10 and 

11 (B) if necessary, the location, apprehension, 

12 arrest, and return to court of an eligible partici13 pant in the program who has absconded from the 

14 facility of a treatment provider or has otherwise 

15 violated the terms and conditions of the pro16 gram, consistent with Federal and State con17 fidentiality requirements; 

18 (4) notify the relevant criminal justice entity if 

19 any eligible participant in the program absconds 

20 from the facility of the treatment provider or other21 wise violates the terms and conditions of the program, 

22 consistent with Federal and State confidentiality re23 quirements; 

24 (5) submit periodic reports on the progress of 

25 treatment or other measured outcomes from participamstockstill on DSK4VPTVN1PROD with BILLS

108 

•S 524 RS

1 tion in the program of each eligible participant in the 

2 program to the relevant State, tribal, or local crimi3 nal justice agency; 

4 (6) describe the evidence-based methodology and 

5 outcome measurements that will be used to evaluate 

6 the program, and specifically explain how such meas7 urements will provide valid measures of the impact of 

8 the program; and 

9 (7) describe how the program could be broadly 

10 replicated if demonstrated to be effective. 

11 (e) USE OF FUNDS.—An eligible entity shall use a 

12 grant received under this section for expenses of a treatment 

13 alternative to incarceration program, including— 

14 (1) salaries, personnel costs, equipment costs, 

15 and other costs directly related to the operation of the 

16 program, including the enforcement unit; 

17 (2) payments for treatment providers that are 

18 approved by the relevant State or tribal jurisdiction 

19 and licensed, if necessary, to provide needed treatment 

20 to eligible participants in the program, including 

21 medication assisted treatment, aftercare supervision, 

22 vocational training, education, and job placement; 

23 (3) payments to public and nonprofit private en24 tities that are approved by the State or tribal juris25 diction and licensed, if necessary, to provide alcohol 

mstockstill on DSK4VPTVN1PROD with BILLS

109 

•S 524 RS

1 and drug addiction treatment and mental health 

2 treatment to eligible participants in the program; and 

3 (4) salaries, personnel costs, and other costs re4 lated to strategic planning among State and local 

5 government agencies. 

6 (f) SUPPLEMENT NOT SUPPLANT.—An eligible entity 

7 shall use Federal funds received under this section only to 

8 supplement the funds that would, in the absence of those 

9 Federal funds, be made available from other Federal and 

10 non-Federal sources for the activities described in this sec11 tion, and not to supplant those funds. 

12 (g) GEOGRAPHIC DISTRIBUTION.—The Secretary of 

13 Health and Human Services shall ensure that, to the extent 

14 practicable, the geographical distribution of grants under 

15 this section is equitable and includes a grant to an eligible 

16 entity in— 

17 (1) each State; 

18 (2) rural, suburban, and urban areas; and 

19 (3) tribal jurisdictions. 

20 (h) PRIORITY CONSIDERATION WITH RESPECT TO

21 STATES.—In awarding grants to States under this section, 

22 the Secretary of Health and Human Services shall give pri23 ority to— 

24 (1) a State that submits a joint application from 

25 the substance abuse agencies and criminal justice 

mstockstill on DSK4VPTVN1PROD with BILLS

110 

•S 524 RS

1 agencies of the State that proposes to use grant funds 

2 to facilitate or enhance planning and collaboration 

3 between the agencies, including coordination to better 

4 address the needs of incarcerated populations; and 

5 (2) a State that— 

6 (A) provides civil liability protection for 

7 first responders, health professionals, and family 

8 members who have received appropriate training 

9 in the administration of naloxone in admin10 istering naloxone to counteract opioid overdoses; 

11 and 

12 (B) submits to the Secretary a certification 

13 by the attorney general of the State that the at14 torney general has— 

15 (i) reviewed any applicable civil liabil16 ity protection law to determine the applica17 bility of the law with respect to first re18 sponders, health care professionals, family 

19 members, and other individuals who— 

20 (I) have received appropriate 

21 training in the administration of 

22 naloxone; and 

23 (II) may administer naloxone to 

24 individuals reasonably believed to be 

25 suffering from opioid overdose; and 

mstockstill on DSK4VPTVN1PROD with BILLS

111 

•S 524 RS

1 (ii) concluded that the law described in 

2 subparagraph (A) provides adequate civil 

3 liability protection applicable to such per4 sons. 

5 (i) REPORTS AND EVALUATIONS.— 

6 (1) IN GENERAL.—Each fiscal year, each recipi7 ent of a grant under this section during that fiscal 

8 year shall submit to the Secretary of Health and 

9 Human Services a report on the outcomes of activities 

10 carried out using that grant in such form, containing 

11 such information, and on such dates as the Secretary 

12 of Health and Human Services shall specify. 

13 (2) CONTENTS.—A report submitted under para14 graph (1) shall— 

15 (A) describe best practices for treatment al16 ternatives; and 

17 (B) identify training requirements for law 

18 enforcement officers who participate in treatment 

19 alternative to incarceration programs. 

20 (j) FUNDING.—During the 5-year period beginning on 

21 the date of enactment of this Act, the Secretary of Health 

22 and Human Services shall carry out this section using 

23 funds made available to the Substance Abuse and Mental 

24 Health Services Administration for Criminal Justice Ac25 tivities. 

mstockstill on DSK4VPTVN1PROD with BILLS

112 

•S 524 RS

1 SEC. 202. FIRST RESPONDER TRAINING FOR THE USE OF 

2 DRUGS AND DEVICES THAT RAPIDLY RE3 VERSE THE EFFECTS OF OPIOIDS. 

4 Part II of title I of the Omnibus Crime Control and 

5 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

6 amended by section 103, is amended by adding at the end 

7 the following: 

8 ‘‘SEC. 2998. FIRST RESPONDER TRAINING FOR THE USE OF 

9 DRUGS AND DEVICES THAT RAPIDLY RE10 VERSE THE EFFECTS OF OPIOIDS. 

11 ‘‘(a) DEFINITION.—In this section— 

12 ‘‘(1) the terms ‘drug’ and ‘device’ have the mean13 ings given those terms in section 201 of the Federal 

14 Food, Drug, and Cosmetic Act (21 U.S.C. 321); 

15 ‘‘(2) the term ‘eligible entity’ means a State, a 

16 unit of local government, or an Indian tribal govern17 ment; 

18 ‘‘(3) the term ‘first responder’ includes a fire19 fighter, law enforcement officer, paramedic, emergency 

20 medical technician, or other individual (including an 

21 employee of a legally organized and recognized volun22 teer organization, whether compensated or not), who, 

23 in the course of professional duties, responds to fire, 

24 medical, hazardous material, or other similar emer25 gencies; and 

mstockstill on DSK4VPTVN1PROD with BILLS

113 

•S 524 RS

1 ‘‘(4) the term ‘Secretary’ means the Secretary of 

2 Health and Human Services. 

3 ‘‘(b) PROGRAM AUTHORIZED.—The Secretary, in co4 ordination with the Attorney General, may make grants to 

5 eligible entities to allow appropriately trained first re6 sponders to administer an opioid overdose reversal drug to 

7 an individual who has— 

8 ‘‘(1) experienced a prescription opioid or heroin 

9 overdose; or 

10 ‘‘(2) been determined to have likely experienced 

11 a prescription opioid or heroin overdose. 

12 ‘‘(c) APPLICATION.— 

13 ‘‘(1) IN GENERAL.—An eligible entity seeking a 

14 grant under this section shall submit an application 

15 to the Secretary— 

16 ‘‘(A) that meets the criteria under para17 graph (2); and 

18 ‘‘(B) at such time, in such manner, and ac19 companied by such information as the Secretary 

20 may require. 

21 ‘‘(2) CRITERIA.—An eligible entity, in submit22 ting an application under paragraph (1), shall— 

23 ‘‘(A) describe the evidence-based method24 ology and outcome measurements that will be 

25 used to evaluate the program funded with a 

mstockstill on DSK4VPTVN1PROD with BILLS

114 

•S 524 RS

1 grant under this section, and specifically explain 

2 how such measurements will provide valid meas3 ures of the impact of the program; 

4 ‘‘(B) describe how the program could be 

5 broadly replicated if demonstrated to be effective; 

6 ‘‘(C) identify the governmental and commu7 nity agencies that the program will coordinate; 

8 and 

9 ‘‘(D) describe how law enforcement agencies 

10 will coordinate with their corresponding State 

11 substance abuse and mental health agencies to 

12 identify protocols and resources that are avail13 able to victims and families, including informa14 tion on treatment and recovery resources. 

15 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

16 grant received under this section to— 

17 ‘‘(1) make such opioid overdose reversal drugs or 

18 devices that are approved by the Food and Drug Ad19 ministration, such as naloxone, available to be car20 ried and administered by first responders; 

21 ‘‘(2) train and provide resources for first re22 sponders on carrying an opioid overdose reversal drug 

23 or device approved by the Food and Drug Adminis24 tration, such as naloxone, and administering the drug 

25 or device to an individual who has experienced, or 

mstockstill on DSK4VPTVN1PROD with BILLS

115 

•S 524 RS

1 has been determined to have likely experienced, a pre2 scription opioid or heroin overdose; and 

3 ‘‘(3) establish processes, protocols, and mecha4 nisms for referral to appropriate treatment. 

5 ‘‘(e) TECHNICAL ASSISTANCE GRANTS.—The Secretary 

6 shall make a grant for the purpose of providing technical 

7 assistance and training on the use of an opioid overdose 

8 reversal drug, such as naloxone, to respond to an individual 

9 who has experienced, or has been determined to have likely 

10 experienced, a prescription opioid or heroin overdose, and 

11 mechanisms for referral to appropriate treatment for an eli12 gible entity receiving a grant under this section. 

13 ‘‘(f) EVALUATION.—The Secretary shall conduct an 

14 evaluation of grants made under this section to determine— 

15 ‘‘(1) the number of first responders equipped 

16 with naloxone, or another opioid overdose reversal 

17 drug, for the prevention of fatal opioid and heroin 

18 overdose; 

19 ‘‘(2) the number of opioid and heroin overdoses 

20 reversed by first responders receiving training and 

21 supplies of naloxone, or another opioid overdose rever22 sal drug, through a grant received under this section; 

23 ‘‘(3) the number of calls for service related to 

24 opioid and heroin overdose; 

mstockstill on DSK4VPTVN1PROD with BILLS

116 

•S 524 RS

1 ‘‘(4) the extent to which overdose victims and 

2 families receive information about treatment services 

3 and available data describing treatment admissions; 

4 and 

5 ‘‘(5) the research, training, and naloxone, or an6 other opioid overdose reversal drug, supply needs of 

7 first responder agencies, including those agencies that 

8 are not receiving grants under this section. 

9 ‘‘(g) RURAL AREAS WITH LIMITED ACCESS TO EMER10 GENCY MEDICAL SERVICES.—In making grants under this 

11 section, the Secretary shall ensure that not less than 25 per12 cent of grant funds are awarded to eligible entities that are 

13 not located in metropolitan statistical areas, as defined by 

14 the Office of Management and Budget.’’. 

15 SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

16 (a) DEFINITION OF COVERED ENTITY.—In this sec17 tion, the term ‘‘covered entity’’ means— 

18 (1) a State, local, or tribal law enforcement 

19 agency; 

20 (2) a manufacturer, distributor, or reverse dis21 tributor of prescription medications; 

22 (3) a retail pharmacy; 

23 (4) a registered narcotic treatment program; 

24 (5) a hospital or clinic with an on-site phar25 macy; 

mstockstill on DSK4VPTVN1PROD with BILLS

117 

•S 524 RS

1 (6) an eligible long-term care facility; or 

2 (7) any other entity authorized by the Drug En3 forcement Administration to dispose of prescription 

4 medications. 

5 (b) PROGRAM AUTHORIZED.—The Attorney General, 

6 in coordination with the Administrator of the Drug En7 forcement Administration, the Secretary of Health and 

8 Human Services, and the Director of the Office of National 

9 Drug Control Policy, shall coordinate with covered entities 

10 in expanding or making available disposal sites for un11 wanted prescription medications. 

12 SEC. 204. HEROIN AND METHAMPHETAMINE TASK FORCES. 

13 Part II of title I of the Omnibus Crime Control and 

14 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

15 amended by section 202, is amended by adding at the end 

16 the following: 

17 ‘‘SEC. 2999. HEROIN AND METHAMPHETAMINE TASK 

18 FORCES. 

19 ‘‘The Attorney General may make grants to State law 

20 enforcement agencies for investigative purposes— 

21 ‘‘(1) to locate or investigate illicit activities 

22 through statewide collaboration, including activities 

23 related to— 

mstockstill on DSK4VPTVN1PROD with BILLS

118 

•S 524 RS

1 ‘‘(A) the distribution of heroin or fentanyl, 

2 or the unlawful distribution of prescription 

3 opioids; or 

4 ‘‘(B) unlawful heroin, fentanyl, and pre5 scription opioid traffickers; and 

6 ‘‘(2) to locate or investigate illicit activities, in7 cluding precursor diversion, laboratories, or meth8 amphetamine traffickers.’’. 

9 TITLE III—TREATMENT AND 

10 RECOVERY 

11 SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT12 MENT AND INTERVENTIONS DEMONSTRA13 TION. 

14 Part II of title I of the Omnibus Crime Control and 

15 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

16 amended by section 204, is amended by adding at the end 

17 the following: 

18 ‘‘SEC. 2999A. EVIDENCE-BASED OPIOID AND HEROIN TREAT19 MENT AND INTERVENTIONS DEMONSTRA20 TION. 

21 ‘‘(a) DEFINITIONS.—In this section— 

22 ‘‘(1) the terms ‘Indian tribe’ and ‘tribal organi23 zation’ have the meaning given those terms in section 

24 4 of the Indian Health Care Improvement Act (25 

25 U.S.C. 1603)); 

mstockstill on DSK4VPTVN1PROD with BILLS

119 

•S 524 RS

1 ‘‘(2) the term ‘medication assisted treatment’ 

2 means the use, for problems relating to heroin and 

3 other opioids, of medications approved by the Food 

4 and Drug Administration in combination with coun5 seling and behavioral therapies; 

6 ‘‘(3) the term ‘Secretary’ means the Secretary of 

7 Health and Human Services; and 

8 ‘‘(4) the term ‘State substance abuse agency’ 

9 means the agency of a State responsible for the State 

10 prevention, treatment, and recovery system, including 

11 management of the Substance Abuse Prevention and 

12 Treatment Block Grant under subpart II of part B 

13 of title XIX of the Public Health Service Act (42 

14 U.S.C. 300x–21 et seq.). 

15 ‘‘(b) GRANTS.— 

16 ‘‘(1) AUTHORITY TO MAKE GRANTS.—The Sec17 retary, acting through the Director of the Center for 

18 Substance Abuse Treatment of the Substance Abuse 

19 and Mental Health Services Administration, and in 

20 coordination with the Attorney General and other de21 partments or agencies, as appropriate, may award 

22 grants to State substance abuse agencies, units of 

23 local government, nonprofit organizations, and In24 dian tribes or tribal organizations that have a high 

25 rate, or have had a rapid increase, in the use of hermstockstill on DSK4VPTVN1PROD with BILLS

120 

•S 524 RS

1 oin or other opioids, in order to permit such entities 

2 to expand activities, including an expansion in the 

3 availability of medication assisted treatment and 

4 other clinically appropriate services, with respect to 

5 the treatment of addiction in the specific geographical 

6 areas of such entities where there is a high rate or 

7 rapid increase in the use of heroin or other opioids. 

8 ‘‘(2) NATURE OF ACTIVITIES.—The grant funds 

9 awarded under paragraph (1) shall be used for activi10 ties that are based on reliable scientific evidence of ef11 ficacy in the treatment of problems related to heroin 

12 or other opioids. 

13 ‘‘(c) GEOGRAPHIC DISTRIBUTION.—The Secretary 

14 shall ensure that grants awarded under subsection (b) are 

15 distributed equitably among the various regions of the 

16 United States and among rural, urban, and suburban areas 

17 that are affected by the use of heroin or other opioids. 

18 ‘‘(d) ADDITIONAL ACTIVITIES.—In administering 

19 grants under subsection (b), the Secretary shall— 

20 ‘‘(1) evaluate the activities supported by grants 

21 awarded under subsection (b); 

22 ‘‘(2) disseminate information, as appropriate, 

23 derived from the evaluation as the Secretary considers 

24 appropriate; 

mstockstill on DSK4VPTVN1PROD with BILLS

121 

•S 524 RS

1 ‘‘(3) provide States, Indian tribes and tribal or2 ganizations, and providers with technical assistance 

3 in connection with the provision of treatment of prob4 lems related to heroin and other opioids; and 

5 ‘‘(4) fund only those applications that specifi6 cally support recovery services as a critical compo7 nent of the grant program.’’. 

8 SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED 

9 TREATMENT AND INTERVENTIONS DEM10 ONSTRATION. 

11 (a) DEFINITIONS.—In this section— 

12 (1) the term ‘‘criminal justice agency’’ means a 

13 State, local, or tribal— 

14 (A) court; 

15 (B) prison; 

16 (C) jail; or 

17 (D) other agency that performs the adminis18 tration of criminal justice, including prosecu19 tion, pretrial services, and community super20 vision; 

21 (2) the term ‘‘eligible entity’’ means a State, 

22 unit of local government, or Indian tribe; and 

23 (3) the term ‘‘Secretary’’ means the Secretary of 

24 Health and Human Services. 

mstockstill on DSK4VPTVN1PROD with BILLS

122 

•S 524 RS

1 (b) PROGRAM AUTHORIZED.—The Secretary, in co2 ordination with the Attorney General, may make grants to 

3 eligible entities to implement medication assisted treatment 

4 programs through criminal justice agencies. 

5 (c) APPLICATION.— 

6 (1) IN GENERAL.—An eligible entity seeking a 

7 grant under this section shall submit an application 

8 to the Secretary— 

9 (A) that meets the criteria under paragraph 

10 (2); and 

11 (B) at such time, in such manner, and ac12 companied by such information as the Secretary 

13 may require. 

14 (2) CRITERIA.—An eligible entity, in submitting 

15 an application under paragraph (1), shall— 

16 (A) certify that each medication assisted 

17 treatment program funded with a grant under 

18 this section has been developed in consultation 

19 with the Single State Authority for Substance 

20 Abuse; and 

21 (B) describe how data will be collected and 

22 analyzed to determine the effectiveness of the pro23 gram described in subparagraph (A). 

24 (d) USE OF FUNDS.—An eligible entity shall use a 

25 grant received under this section for expenses of— 

mstockstill on DSK4VPTVN1PROD with BILLS

123 

•S 524 RS

1 (1) a medication assisted treatment program, in2 cluding the expenses of prescribing medications recog3 nized by the Food and Drug Administration for 

4 opioid treatment in conjunction with psychological 

5 and behavioral therapy; 

6 (2) training criminal justice agency personnel 

7 and treatment providers on medication assisted treat8 ment; 

9 (3) cross-training personnel providing behavioral 

10 health and health services, administration of medi11 cines, and other administrative expenses, including 

12 required reports; and 

13 (4) the provision of recovery coaches who are re14 sponsible for providing mentorship and transition 

15 plans to individuals reentering society following in16 carceration or alternatives to incarceration. 

17 (e) PRIORITY CONSIDERATION WITH RESPECT TO

18 STATES.—In awarding grants to States under this section, 

19 the Secretary shall give priority to a State that— 

20 (1) provides civil liability protection for first re21 sponders, health professionals, and family members 

22 who have received appropriate training in the admin23 istration of naloxone in administering naloxone to 

24 counteract opioid overdoses; and 

mstockstill on DSK4VPTVN1PROD with BILLS

124 

•S 524 RS

1 (2) submits to the Secretary a certification by 

2 the attorney general of the State that the attorney 

3 general has— 

4 (A) reviewed any applicable civil liability 

5 protection law to determine the applicability of 

6 the law with respect to first responders, health 

7 care professionals, family members, and other in8 dividuals who— 

9 (i) have received appropriate training 

10 in the administration of naloxone; and 

11 (ii) may administer naloxone to indi12 viduals reasonably believed to be suffering 

13 from opioid overdose; and 

14 (B) concluded that the law described in sub15 paragraph (A) provides adequate civil liability 

16 protection applicable to such persons. 

17 (f) TECHNICAL ASSISTANCE.—The Secretary, in co18 ordination with the Director of the National Institute on 

19 Drug Abuse and the Attorney General, shall provide tech20 nical assistance and training for an eligible entity receiving 

21 a grant under this section. 

22 (g) REPORTS.— 

23 (1) IN GENERAL.—An eligible entity receiving a 

24 grant under this section shall submit a report to the 

25 Secretary on the outcomes of each grant received 

mstockstill on DSK4VPTVN1PROD with BILLS

125 

•S 524 RS

1 under this section for individuals receiving medica2 tion assisted treatment, based on— 

3 (A) the recidivism of the individuals; 

4 (B) the treatment outcomes of the individ5 uals, including maintaining abstinence from ille6 gal, unauthorized, and unprescribed or 

7 undispensed opioids and heroin; 

8 (C) a comparison of the cost of providing 

9 medication assisted treatment to the cost of in10 carceration or other participation in the crimi11 nal justice system; 

12 (D) the housing status of the individuals; 

13 and 

14 (E) the employment status of the individ15 uals. 

16 (2) CONTENTS AND TIMING.—Each report de17 scribed in paragraph (1) shall be submitted annually 

18 in such form, containing such information, and on 

19 such dates as the Secretary shall specify. 

20 (h) FUNDING.—During the 5-year period beginning on 

21 the date of enactment of this Act, the Secretary shall carry 

22 out this section using funds made available to the Substance 

23 Abuse and Mental Health Services Administration for 

24 Criminal Justice Activities. 

mstockstill on DSK4VPTVN1PROD with BILLS

126 

•S 524 RS

1 SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE. 

2 Part II of title I of the Omnibus Crime Control and 

3 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

4 amended by section 301, is amended by adding at the end 

5 the following: 

6 ‘‘SEC. 2999B. NATIONAL YOUTH RECOVERY INITIATIVE. 

7 ‘‘(a) DEFINITIONS.—In this section: 

8 ‘‘(1) ELIGIBLE ENTITY.—The term ‘eligible enti9 ty’ means— 

10 ‘‘(A) a high school that has been accredited 

11 as a recovery high school by the Association of 

12 Recovery Schools; 

13 ‘‘(B) an accredited high school that is seek14 ing to establish or expand recovery support serv15 ices; 

16 ‘‘(C) an institution of higher education; 

17 ‘‘(D) a recovery program at a nonprofit col18 legiate institution; or 

19 ‘‘(E) a nonprofit organization. 

20 ‘‘(2) INSTITUTION OF HIGHER EDUCATION.—The 

21 term ‘institution of higher education’ has the meaning 

22 given the term in section 101 of the Higher Education 

23 Act of 1965 (20 U.S.C. 1001). 

24 ‘‘(3) RECOVERY PROGRAM.—The term ‘recovery 

25 program’— 

mstockstill on DSK4VPTVN1PROD with BILLS

127 

•S 524 RS

1 ‘‘(A) means a program to help individuals 

2 who are recovering from substance use disorders 

3 to initiate, stabilize, and maintain healthy and 

4 productive lives in the community; and 

5 ‘‘(B) includes peer-to-peer support and com6 munal activities to build recovery skills and sup7 portive social networks. 

8 ‘‘(b) GRANTS AUTHORIZED.—The Secretary of Health 

9 and Human Services, in coordination with the Secretary 

10 of Education, may award grants to eligible entities to en11 able the entities to— 

12 ‘‘(1) provide substance use recovery support serv13 ices to young people in high school and enrolled in in14 stitutions of higher education; 

15 ‘‘(2) help build communities of support for 

16 young people in recovery through a spectrum of ac17 tivities such as counseling and health- and wellness18 oriented social activities; and 

19 ‘‘(3) encourage initiatives designed to help young 

20 people achieve and sustain recovery from substance 

21 use disorders. 

22 ‘‘(c) USE OF FUNDS.—Grants awarded under sub23 section (b) may be used for activities to develop, support, 

24 and maintain youth recovery support services, including— 

mstockstill on DSK4VPTVN1PROD with BILLS

128 

•S 524 RS

1 ‘‘(1) the development and maintenance of a dedi2 cated physical space for recovery programs; 

3 ‘‘(2) dedicated staff for the provision of recovery 

4 programs; 

5 ‘‘(3) health- and wellness-oriented social activi6 ties and community engagement; 

7 ‘‘(4) establishment of recovery high schools; 

8 ‘‘(5) coordination of recovery programs with— 

9 ‘‘(A) substance use disorder treatment pro10 grams and systems; 

11 ‘‘(B) providers of mental health services; 

12 ‘‘(C) primary care providers and physi13 cians; 

14 ‘‘(D) the criminal justice system, including 

15 the juvenile justice system; 

16 ‘‘(E) employers; 

17 ‘‘(F) housing services; 

18 ‘‘(G) child welfare services; 

19 ‘‘(H) high schools and institutions of higher 

20 education; and 

21 ‘‘(I) other programs or services related to 

22 the welfare of an individual in recovery from a 

23 substance use disorder; 

24 ‘‘(6) the development of peer-to-peer support pro25 grams or services; and 

mstockstill on DSK4VPTVN1PROD with BILLS

129 

•S 524 RS

1 ‘‘(7) additional activities that help youths and 

2 young adults to achieve recovery from substance use 

3 disorders.’’. 

4 SEC. 304. BUILDING COMMUNITIES OF RECOVERY. 

5 Part II of title I of the Omnibus Crime Control and 

6 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

7 amended by section 303, is amended by adding at the end 

8 the following: 

9 ‘‘SEC. 2999C. BUILDING COMMUNITIES OF RECOVERY. 

10 ‘‘(a) DEFINITION.—In this section, the term ‘recovery 

11 community organization’ means an independent nonprofit 

12 organization that— 

13 ‘‘(1) mobilizes resources within and outside of 

14 the recovery community to increase the prevalence 

15 and quality of long-term recovery from substance use 

16 disorders; and 

17 ‘‘(2) is wholly or principally governed by people 

18 in recovery for substance use disorders who reflect the 

19 community served. 

20 ‘‘(b) GRANTS AUTHORIZED.—The Secretary of Health 

21 and Human Services may award grants to recovery com22 munity organizations to enable such organizations to de23 velop, expand, and enhance recovery services. 

mstockstill on DSK4VPTVN1PROD with BILLS

130 

•S 524 RS

1 ‘‘(c) FEDERAL SHARE.—The Federal share of the costs 

2 of a program funded by a grant under this section may 

3 not exceed 50 percent. 

4 ‘‘(d) USE OF FUNDS.—Grants awarded under sub5 section (b)— 

6 ‘‘(1) shall be used to develop, expand, and en7 hance community and statewide recovery support 

8 services; and 

9 ‘‘(2) may be used to— 

10 ‘‘(A) advocate for individuals in recovery 

11 from substance use disorders; 

12 ‘‘(B) build connections between recovery 

13 networks, between recovery community organiza14 tions, and with other recovery support services, 

15 including— 

16 ‘‘(i) substance use disorder treatment 

17 programs and systems; 

18 ‘‘(ii) providers of mental health serv19 ices; 

20 ‘‘(iii) primary care providers and phy21 sicians; 

22 ‘‘(iv) the criminal justice system; 

23 ‘‘(v) employers; 

24 ‘‘(vi) housing services; 

25 ‘‘(vii) child welfare agencies; and 

mstockstill on DSK4VPTVN1PROD with BILLS

131 

•S 524 RS

1 ‘‘(viii) other recovery support services 

2 that facilitate recovery from substance use 

3 disorders; 

4 ‘‘(C) reduce the stigma associated with sub5 stance use disorders; 

6 ‘‘(D) conduct public education and outreach 

7 on issues relating to substance use disorders and 

8 recovery, including— 

9 ‘‘(i) how to identify the signs of addic10 tion; 

11 ‘‘(ii) the resources that are available to 

12 individuals struggling with addiction and 

13 families who have a family member strug14 gling with or being treated for addiction, 

15 including programs that mentor and pro16 vide support services to children; 

17 ‘‘(iii) the resources that are available 

18 to help support individuals in recovery; and 

19 ‘‘(iv) information on the medical con20 sequences of substance use disorders, includ21 ing neonatal abstinence syndrome and po22 tential infection with human immuno23 deficiency virus and viral hepatitis; and 

mstockstill on DSK4VPTVN1PROD with BILLS

132 

•S 524 RS

1 ‘‘(E) carry out other activities that 

2 strengthen the network of community support for 

3 individuals in recovery.’’. 

4 TITLE IV—ADDRESSING 

5 COLLATERAL CONSEQUENCES 

6 SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION 

7 GRANT PROGRAM. 

8 Part II of title I of the Omnibus Crime Control and 

9 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

10 amended by section 304, is amended by adding at the end 

11 the following: 

12 ‘‘SEC. 2999D. CORRECTIONAL EDUCATION DEMONSTRATION 

13 GRANT PROGRAM. 

14 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

15 entity’ means a State, unit of local government, nonprofit 

16 organization, or Indian tribe. 

17 ‘‘(b) GRANT PROGRAM AUTHORIZED.—The Attorney 

18 General may make grants to eligible entities to design, im19 plement, and expand educational programs for offenders in 

20 prisons, jails, and juvenile facilities, including to pay for— 

21 ‘‘(1) basic education, secondary level academic 

22 education, high school equivalency examination prep23 aration, career technical education, and English as a 

24 second language instruction at the basic, secondary, 

mstockstill on DSK4VPTVN1PROD with BILLS

133 

•S 524 RS

1 or post-secondary levels, for adult and juvenile popu2 lations; 

3 ‘‘(2) screening and assessment of inmates to as4 sess education level, needs, occupational interest or 

5 aptitude, risk level, and other needs, and case man6 agement services; 

7 ‘‘(3) hiring and training of instructors and 

8 aides, reimbursement of non-corrections staff and ex9 perts, reimbursement of stipends paid to inmate tu10 tors or aides, and the costs of training inmate tutors 

11 and aides; 

12 ‘‘(4) instructional supplies and equipment, in13 cluding occupational program supplies and equip14 ment to the extent that the supplies and equipment 

15 are used for instructional purposes; 

16 ‘‘(5) partnerships and agreements with commu17 nity colleges, universities, and career technology edu18 cation program providers; 

19 ‘‘(6) certification programs providing recognized 

20 high school equivalency certificates and industry rec21 ognized credentials; and 

22 ‘‘(7) technology solutions to— 

23 ‘‘(A) meet the instructional, assessment, and 

24 information needs of correctional populations; 

25 and 

mstockstill on DSK4VPTVN1PROD with BILLS

134 

•S 524 RS

1 ‘‘(B) facilitate the continued participation 

2 of incarcerated students in community-based 

3 education programs after the students are re4 leased from incarceration. 

5 ‘‘(c) APPLICATION.—An eligible entity seeking a grant 

6 under this section shall submit to the Attorney General an 

7 application in such form and manner, at such time, and 

8 accompanied by such information as the Attorney General 

9 specifies. 

10 ‘‘(d) PRIORITY CONSIDERATIONS.—In awarding 

11 grants under this section, the Attorney General shall give 

12 priority to applicants that— 

13 ‘‘(1) assess the level of risk and need of inmates, 

14 including by— 

15 ‘‘(A) assessing the need for English as a sec16 ond language instruction; 

17 ‘‘(B) conducting educational assessments; 

18 and 

19 ‘‘(C) assessing occupational interests and 

20 aptitudes; 

21 ‘‘(2) target educational services to assessed needs, 

22 including academic and occupational at the basic, 

23 secondary, or post-secondary level; 

24 ‘‘(3) target career technology education programs 

25 to— 

mstockstill on DSK4VPTVN1PROD with BILLS

135 

•S 524 RS

1 ‘‘(A) areas of identified occupational de2 mand; and 

3 ‘‘(B) employment opportunities in the com4 munities in which students are reasonably ex5 pected to reside post-release; 

6 ‘‘(4) include a range of appropriate educational 

7 opportunities at the basic, secondary, and post-sec8 ondary levels; 

9 ‘‘(5) include opportunities for students to attain 

10 industry recognized credentials; 

11 ‘‘(6) include partnership or articulation agree12 ments linking institutional education programs with 

13 community sited programs provided by adult edu14 cation program providers and accredited institutions 

15 of higher education, community colleges, and voca16 tional training institutions; and 

17 ‘‘(7) explicitly include career pathways models 

18 offering opportunities for incarcerated students to de19 velop academic skills, in-demand occupational skills 

20 and credentials, occupational experience in institu21 tional work programs or work release programs, and 

22 linkages with employers in the community, so that 

23 incarcerated students have opportunities to embark on 

24 careers with strong prospects for both post-release emmstockstill on DSK4VPTVN1PROD with BILLS

136 

•S 524 RS

1 ployment and advancement in a career ladder over 

2 time. 

3 ‘‘(e) REQUIREMENTS.—An eligible entity desiring a 

4 grant under this section shall— 

5 ‘‘(1) describe the evidence-based methodology and 

6 outcome measurements that will be used to evaluate 

7 each program funded with a grant under this section, 

8 and specifically explain how such measurements will 

9 provide valid measures of the impact of the program; 

10 and 

11 ‘‘(2) describe how the program described in para12 graph (1) could be broadly replicated if demonstrated 

13 to be effective. 

14 ‘‘(f) CONTROL OF INTERNET ACCESS.—An entity that 

15 receives a grant under this section may restrict access to 

16 the Internet by prisoners, as appropriate and in accordance 

17 with Federal and State law, to ensure public safety.’’. 

18 SEC. 402. NATIONAL TASK FORCE ON RECOVERY AND COL19 LATERAL CONSEQUENCES. 

20 (a) DEFINITION.—In this section, the term ‘‘collateral 

21 consequence’’ means a penalty, disability, or disadvantage 

22 imposed on an individual who is in recovery for a substance 

23 use disorder (including by an administrative agency, offi24 cial, or civil court ) as a result of a Federal or State convicmstockstill on DSK4VPTVN1PROD with BILLS

137 

•S 524 RS

1 tion for a drug-related offense but not as part of the judg2 ment of the court that imposes the conviction. 

3 (b) ESTABLISHMENT.— 

4 (1) IN GENERAL.—Not later than 30 days after 

5 the date of enactment of this Act, the Attorney Gen6 eral shall establish a bipartisan task force to be 

7 known as the Task Force on Recovery and Collateral 

8 Consequences (in this section referred to as the ‘‘Task 

9 Force’’). 

10 (2) MEMBERSHIP.— 

11 (A) TOTAL NUMBER OF MEMBERS.—The 

12 Task Force shall include 10 members, who shall 

13 be appointed by the Attorney General in accord14 ance with subparagraphs (B) and (C). 

15 (B) MEMBERS OF THE TASK FORCE.—The 

16 Task Force shall include— 

17 (i) members who have national rec18 ognition and significant expertise in areas 

19 such as health care, housing, employment, 

20 substance use disorders, mental health, law 

21 enforcement, and law; 

22 (ii) not fewer than 2 members— 

23 (I) who have personally experi24 enced substance abuse or addiction and 

25 are in recovery; and 

mstockstill on DSK4VPTVN1PROD with BILLS

138 

•S 524 RS

1 (II) not fewer than 1 one of whom 

2 has benefitted from medication assisted 

3 treatment; and 

4 (iii) to the extent practicable, members 

5 who formerly served as elected officials at 

6 the State and Federal levels. 

7 (C) TIMING.—The Attorney General shall 

8 appoint the members of the Task Force not later 

9 than 60 days after the date on which the Task 

10 Force is established under paragraph (1). 

11 (3) CHAIRPERSON.—The Task Force shall select 

12 a chairperson or co-chairpersons from among the 

13 members of the Task Force. 

14 (c) DUTIES OF THE TASK FORCE.— 

15 (1) IN GENERAL.—The Task Force shall— 

16 (A) identify collateral consequences for indi17 viduals with Federal or State convictions for 

18 drug-related offenses who are in recovery for sub19 stance use disorder; and 

20 (B) examine any policy basis for the impo21 sition of collateral consequences identified under 

22 subparagraph (A) and the effect of the collateral 

23 consequences on individuals in recovery from re24 suming their personal and professional activi25 ties. 

mstockstill on DSK4VPTVN1PROD with BILLS

139 

•S 524 RS

1 (2) RECOMMENDATIONS.—Not later than 180 

2 days after the date of the first meeting of the Task 

3 Force, the Task Force shall develop recommendations, 

4 as it considers appropriate, for proposed legislative 

5 and regulatory changes related to the collateral con6 sequences identified under paragraph (1). 

7 (3) COLLECTION OF INFORMATION.—The Task 

8 Force shall hold hearings, require the testimony and 

9 attendance of witnesses, and secure information from 

10 any department or agency of the United States in 

11 performing the duties under paragraphs (1) and (2). 

12 (4) REPORT.— 

13 (A) SUBMISSION TO EXECUTIVE BRANCH.— 

14 Not later than 1 year after the date of the first 

15 meeting of the Task Force, the Task Force shall 

16 submit a report detailing the findings and rec17 ommendations of the Task Force to— 

18 (i) the head of each relevant depart19 ment or agency of the United States; 

20 (ii) the President; and 

21 (iii) the Vice President. 

22 (B) SUBMISSION TO CONGRESS.—The indi23 viduals who receive the report under subpara24 graph (A) shall submit to Congress such legislamstockstill on DSK4VPTVN1PROD with BILLS

140 

•S 524 RS

1 tive recommendations, if any, as those individ2 uals consider appropriate based on the report. 

3 TITLE V—ADDICTION AND 

4 TREATMENT SERVICES FOR 

5 WOMEN, FAMILIES, AND VET6 ERANS 

7 SEC. 501. IMPROVING TREATMENT FOR PREGNANT AND 

8 POSTPARTUM WOMEN. 

9 Part II of title I of the Omnibus Crime Control and 

10 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

11 amended by section 401, is amended by adding at the end 

12 the following: 

13 ‘‘SEC. 2999E. IMPROVING TREATMENT FOR PREGNANT AND 

14 POSTPARTUM WOMEN. 

15 ‘‘(a) IN GENERAL.—The Secretary of Health and 

16 Human Services (referred to in this section as the ‘Sec17 retary’), acting through the Director of the Center for Sub18 stance Abuse Treatment, may carry out a pilot program 

19 under which the Secretary makes competitive grants to 

20 State substance abuse agencies to— 

21 ‘‘(1) enhance flexibility in the use of funds de22 signed to support family-based services for pregnant 

23 and postpartum women with a primary diagnosis of 

24 a substance use disorder, including opioid use dis25 orders; 

mstockstill on DSK4VPTVN1PROD with BILLS

141 

•S 524 RS

1 ‘‘(2) help State substance abuse agencies address 

2 identified gaps in services furnished to such women 

3 along the continuum of care, including services pro4 vided to women in non-residential based settings; and 

5 ‘‘(3) promote a coordinated, effective, and effi6 cient State system managed by State substance abuse 

7 agencies by encouraging new approaches and models 

8 of service delivery that are evidence-based, including 

9 effective family-based programs for women involved 

10 with the criminal justice system. 

11 ‘‘(b) REQUIREMENTS.—In carrying out the pilot pro12 gram under this section, the Secretary— 

13 ‘‘(1) shall require State substance abuse agencies 

14 to submit to the Secretary applications, in such form 

15 and manner and containing such information as 

16 specified by the Secretary, to be eligible to receive a 

17 grant under the program; 

18 ‘‘(2) shall identify, based on such submitted ap19 plications, State substance abuse agencies that are eli20 gible for such grants; 

21 ‘‘(3) shall require services proposed to be fur22 nished through such a grant to support family-based 

23 treatment and other services for pregnant and 

24 postpartum women with a primary diagnosis of a 

25 substance use disorder, including opioid use disorders; 

mstockstill on DSK4VPTVN1PROD with BILLS

142 

•S 524 RS

1 ‘‘(4) shall not require that services furnished 

2 through such a grant be provided solely to women 

3 that reside in facilities; and 

4 ‘‘(5) shall not require that grant recipients under 

5 the program make available all services described in 

6 section 508(d) of the Public Health Service Act (42 

7 U.S.C. 290bb–1(d)). 

8 ‘‘(c) REQUIRED SERVICES.— 

9 ‘‘(1) IN GENERAL.—The Secretary shall specify 

10 minimum services required to be made available to el11 igible women through a grant awarded under the 

12 pilot program under this section. Such minimum 

13 services— 

14 ‘‘(A) shall include the requirements de15 scribed in section 508(c) of the Public Health 

16 Service Act (42 U.S.C. 290bb–1(c)); 

17 ‘‘(B) may include any of the services de18 scribed in section 508(d) of the Public Health 

19 Service Act (42 U.S.C. 290bb–1(d)); 

20 ‘‘(C) may include other services, as appro21 priate; and 

22 ‘‘(D) shall be based on the recommendations 

23 submitted under paragraph (2). 

24 ‘‘(2) STAKEHOLDER INPUT.—The Secretary shall 

25 convene and solicit recommendations from stakemstockstill on DSK4VPTVN1PROD with BILLS

143 

•S 524 RS

1 holders, including State substance abuse agencies, 

2 health care providers, persons in recovery from a sub3 stance use disorder, and other appropriate individ4 uals, for the minimum services described in para5 graph (1). 

6 ‘‘(d) DURATION.—The pilot program under this sec7 tion shall not exceed 5 years. 

8 ‘‘(e) EVALUATION AND REPORT TO CONGRESS.— 

9 ‘‘(1) IN GENERAL.—Out of amounts made avail10 able to the Center for Behavioral Health Statistics 

11 and Quality, the Director of the Center for Behavioral 

12 Health Statistics and Quality, in cooperation with 

13 the recipients of grants under this section, shall con14 duct an evaluation of the pilot program, beginning 1 

15 year after the date on which a grant is first awarded 

16 under this section. The Director of the Center for Be17 havioral Health Statistics and Quality, in coordina18 tion with the Director of the Center for Substance 

19 Abuse Treatment, not later than 120 days after com20 pletion of such evaluation, shall submit to the relevant 

21 Committees of the Senate and the House of Represent22 atives a report on such evaluation. 

23 ‘‘(2) CONTENTS.—The report to Congress under 

24 paragraph (1) shall include, at a minimum, outcomes 

25 information from the pilot program, including any 

mstockstill on DSK4VPTVN1PROD with BILLS

144 

•S 524 RS

1 resulting reductions in the use of alcohol and other 

2 drugs, engagement in treatment services, retention in 

3 the appropriate level and duration of services, in4 creased access to the use of drugs approved by the 

5 Food and Drug Administration for the treatment of 

6 substance use disorders in combination with coun7 seling, and other appropriate measures. 

8 ‘‘(f) STATE SUBSTANCE ABUSE AGENCY DEFINED.— 

9 For purposes of this section, the term ‘State substance abuse 

10 agency’ means, with respect to a State, the agency in such 

11 State that manages the substance abuse prevention and 

12 treatment block grant program under part B of title XIX 

13 of the Public Health Service Act.’’. 

14 SEC. 502. REPORT ON GRANTS FOR FAMILY-BASED SUB15 STANCE ABUSE TREATMENT. 

16 Section 2925 of the Omnibus Crime Control and Safe 

17 Streets Act of 1968 (42 U.S.C. 3797s–4) is amended— 

18 (1) by striking ‘‘An entity’’ and inserting ‘‘(a) 

19 ENTITY REPORTS.—An entity’’; and 

20 (2) by adding at the end the following: 

21 ‘‘(b) ATTORNEY GENERAL REPORT ON FAMILY-BASED

22 SUBSTANCE ABUSE TREATMENT.—The Attorney General 

23 shall submit to Congress an annual report that describes 

24 the number of grants awarded under section 2921(1) and 

25 how such grants are used by the recipients for family-based 

mstockstill on DSK4VPTVN1PROD with BILLS

145 

•S 524 RS

1 substance abuse treatment programs that serve as alter2 natives to incarceration for custodial parents to receive 

3 treatment and services as a family.’’. 

4 SEC. 503. VETERANS’ TREATMENT COURTS. 

5 Section 2991(j)(1)(B)(ii) of title I of the Omnibus 

6 Crime Control and Safe Streets Act of 1968 (42 U.S.C. 

7 3797aa(j)(1)(B)(ii)) is amended— 

8 (1) by inserting ‘‘(I)’’ after ‘‘(ii)’’; 

9 (2) in subclause (I), as so designated, by striking 

10 the period and inserting ‘‘; or’’; and 

11 (3) by adding at the end the following: 

12 ‘‘(II) was discharged or released from 

13 such service under dishonorable conditions, 

14 if the reason for that discharge or release, if 

15 known, is attributable to drug use.’’. 

16 TITLE VI—INCENTIVIZING STATE 

17 COMPREHENSIVE INITIA18 TIVES TO ADDRESS OPIOID 

19 AND HEROIN ABUSE 

20 SEC. 601. STATE DEMONSTRATION GRANTS FOR COM21 PREHENSIVE OPIOID ABUSE RESPONSE. 

22 (a) DEFINITIONS.—In this section— 

23 (1) the term ‘‘dispenser’’ has the meaning given 

24 the term in section 102 of the Controlled Substances 

25 Act (21 U.S.C. 802); 

mstockstill on DSK4VPTVN1PROD with BILLS

146 

•S 524 RS

1 (2) the term ‘‘prescriber of a schedule II, III, or 

2 IV controlled substance’’ does not include a prescriber 

3 of a schedule II, III, or IV controlled substance that 

4 dispenses the substance— 

5 (A) for use on the premises on which the 

6 substance is dispensed; 

7 (B) in a hospital emergency room, when the 

8 substance is in short supply; 

9 (C) for a certified opioid treatment pro10 gram; or 

11 (D) in other situations as the Attorney Gen12 eral may reasonably determine; 

13 (3) the term ‘‘prescriber’’ means a dispenser who 

14 prescribes a controlled substance, or the agent of such 

15 a dispenser; and 

16 (4) the term ‘‘schedule II, III, or IV controlled 

17 substance’’ means a controlled substance that is listed 

18 on schedule II, schedule III, or schedule IV of section 

19 202(c) of the Controlled Substances Act (21 U.S.C. 

20 812(c)). 

21 (b) PLANNING AND IMPLEMENTATION GRANTS.— 

22 (1) IN GENERAL.—The Attorney General, in co23 ordination with the Secretary of Health and Human 

24 Services and in consultation with the Director of the 

25 Office of National Drug Control Policy, may award 

mstockstill on DSK4VPTVN1PROD with BILLS

147 

•S 524 RS

1 grants to States, and combinations thereof, to prepare 

2 a comprehensive plan for and implement an inte3 grated opioid abuse response initiative. 

4 (2) PURPOSES.—A State receiving a grant under 

5 this section shall establish a comprehensive response 

6 to opioid abuse, which shall include— 

7 (A) prevention and education efforts around 

8 heroin and opioid use, treatment, and recovery, 

9 including education of residents, medical stu10 dents, and physicians and other prescribers of 

11 schedule II, III, or IV controlled substances on 

12 relevant prescribing guidelines and the prescrip13 tion drug monitoring program of the State ; 

14 (B) a comprehensive prescription drug 

15 monitoring program to track dispensing of 

16 schedule II, III, or IV controlled substances, 

17 which shall— 

18 (i) provide for data sharing with other 

19 States by statute, regulation, or interstate 

20 agreement; and 

21 (ii) allow for access to all individuals 

22 authorized by the State to write prescrip23 tions for schedule II, III, or IV controlled 

24 substances on the prescription drug moni25 toring program of the State. 

mstockstill on DSK4VPTVN1PROD with BILLS

148 

•S 524 RS

1 (C) developing, implementing, or expanding 

2 prescription drug and opioid addiction treat3 ment programs by— 

4 (i) expanding programs for medication 

5 assisted treatment of prescription drug and 

6 opioid addiction, including training for 

7 treatment and recovery support providers; 

8 (ii) developing, implementing, or ex9 panding programs for behavioral health 

10 therapy for individuals who are in treat11 ment for prescription drug and opioid ad12 diction; 

13 (iii) developing, implementing, or ex14 panding programs to screen individuals 

15 who are in treatment for prescription drug 

16 and opioid addiction for hepatitis C and 

17 HIV, and provide treatment for those indi18 viduals if clinically appropriate; or 

19 (iv) developing, implementing, or ex20 panding programs that provide screening, 

21 early intervention, and referral to treatment 

22 (commonly known as ‘‘SBIRT’’) to teen23 agers and young adults in primary care, 

24 middle schools, high schools, universities, 

25 school-based health centers, and other commstockstill on DSK4VPTVN1PROD with BILLS

149 

•S 524 RS

1 munity-based health care settings frequently 

2 accessed by teenagers or young adults; and 

3 (D) developing, implementing, and expand4 ing programs to prevent overdose death from pre5 scription medications and opioids. 

6 (3) PLANNING GRANT APPLICATIONS.— 

7 (A) APPLICATION.— 

8 (i) IN GENERAL.—A State seeking a 

9 planning grant under this section to pre10 pare a comprehensive plan for an inte11 grated opioid abuse response initiative shall 

12 submit to the Attorney General an applica13 tion in such form, and containing such in14 formation, as the Attorney General may re15 quire. 

16 (ii) REQUIREMENTS.—An application 

17 for a planning grant under this section 

18 shall, at a minimum, include— 

19 (I) a budget and a budget jus20 tification for the activities to be car21 ried out using the grant; 

22 (II) a description of the activities 

23 proposed to be carried out using the 

24 grant, including a schedule for comple25 tion of such activities; 

mstockstill on DSK4VPTVN1PROD with BILLS

150 

•S 524 RS

1 (III) outcome measures that will 

2 be used to measure the effectiveness of 

3 the programs and initiatives to address 

4 opioids; and 

5 (IV) a description of the personnel 

6 necessary to complete such activities. 

7 (B) PERIOD; NONRENEWABILITY.—A plan8 ning grant under this section shall be for a pe9 riod of 1 year. A State may not receive more 

10 than 1 planning grant under this section. 

11 (C) AMOUNT.—A planning grant under this 

12 section may not exceed $100,000. 

13 (D) STRATEGIC PLAN AND PROGRAM IMPLE14 MENTATION PLAN.—A State receiving a planning 

15 grant under this section shall develop a strategic 

16 plan and a program implementation plan. 

17 (4) IMPLEMENTATION GRANTS.— 

18 (A) APPLICATION.—A State seeking an im19 plementation grant under this section to imple20 ment a comprehensive strategy for addressing 

21 opioid abuse shall submit to the Attorney Gen22 eral an application in such form, and con23 taining such information, as the Attorney Gen24 eral may require. 

mstockstill on DSK4VPTVN1PROD with BILLS

151 

•S 524 RS

1 (B) USE OF FUNDS.—A State that receives 

2 an implementation grant under this section shall 

3 use the grant for the cost of carrying out an inte4 grated opioid abuse response program in accord5 ance with this section, including for technical as6 sistance, training, and administrative expenses. 

7 (C) REQUIREMENTS.—An integrated opioid 

8 abuse response program carried out using an im9 plementation grant under this section shall— 

10 (i) require that each prescriber of a 

11 schedule II, III, or IV controlled substance 

12 in the State— 

13 (I) registers with the prescription 

14 drug monitoring program of the State; 

15 and 

16 (II) consults the prescription drug 

17 monitoring program database of the 

18 State before prescribing a schedule II, 

19 III, or IV controlled substance; 

20 (ii) require that each dispenser of a 

21 schedule II, III, or IV controlled substance 

22 in the State— 

23 (I) registers with the prescription 

24 drug monitoring program of the State; 

mstockstill on DSK4VPTVN1PROD with BILLS

152 

•S 524 RS

1 (II) consults the prescription drug 

2 monitoring program database of the 

3 State before dispensing a schedule II, 

4 III, or IV controlled substance; and 

5 (III) reports to the prescription 

6 drug monitoring program of the State, 

7 at a minimum, each instance in which 

8 a schedule II, III, or IV controlled sub9 stance is dispensed, with limited excep10 tions, as defined by the State, which 

11 shall indicate the prescriber by name 

12 and National Provider Identifier; 

13 (iii) require that, not fewer than 4 

14 times each year, the State agency or agen15 cies that administer the prescription drug 

16 monitoring program of the State prepare 

17 and provide to each prescriber of a schedule 

18 II, III, or IV controlled substance an infor19 mational report that shows how the pre20 scribing patterns of the prescriber compare 

21 to prescribing practices of the peers of the 

22 prescriber and expected norms; 

23 (iv) if informational reports provided 

24 to a prescriber under clause (iii) indicate 

25 that the prescriber is repeatedly falling outmstockstill on DSK4VPTVN1PROD with BILLS

153 

•S 524 RS

1 side of expected norms or standard practices 

2 for the prescriber’s field, direct the pre3 scriber to educational resources on appro4 priate prescribing of controlled substances; 

5 (v) ensure that the prescriber licensing 

6 board of the State receives a report describ7 ing any prescribers that repeatedly fall out8 side of expected norms or standard practices 

9 for the prescriber’s field, as described in 

10 clause (iii); 

11 (vi) require consultation with the Sin12 gle State Authority for Substance Abuse; 

13 and 

14 (vii) establish requirements for how 

15 data will be collected and analyzed to deter16 mine the effectiveness of the program. 

17 (D) PERIOD.—An implementation grant 

18 under this section shall be for a period of 2 

19 years. 

20 (E) AMOUNT.—The amount of an imple21 mentation grant under this section may not ex22 ceed $5,000,000. 

23 (5) PRIORITY CONSIDERATIONS.—In awarding 

24 planning and implementation grants under this secmstockstill on DSK4VPTVN1PROD with BILLS

154 

•S 524 RS

1 tion, the Attorney General shall give priority to a 

2 State that— 

3 (A)(i) provides civil liability protection for 

4 first responders, health professionals, and family 

5 members who have received appropriate training 

6 in the administration of naloxone in admin7 istering naloxone to counteract opioid overdoses; 

8 and 

9 (ii) submits to the Attorney General a cer10 tification by the attorney general of the State 

11 that the attorney general has— 

12 (I) reviewed any applicable civil liabil13 ity protection law to determine the applica14 bility of the law with respect to first re15 sponders, health care professionals, family 

16 members, and other individuals who— 

17 (aa) have received appropriate 

18 training in the administration of 

19 naloxone; and 

20 (bb) may administer naloxone to 

21 individuals reasonably believed to be 

22 suffering from opioid overdose; and 

23 (II) concluded that the law described 

24 in subclause (I) provides adequate civil limstockstill on DSK4VPTVN1PROD with BILLS

155 

•S 524 RS

1 ability protection applicable to such per2 sons; 

3 (B) has in effect legislation or implements 

4 a policy under which the State shall not termi5 nate, but may suspend, enrollment under the 

6 State plan for medical assistance under title XIX 

7 of the Social Security Act (42 U.S.C. 1396 et 

8 seq.) for an individual who is incarcerated for a 

9 period of fewer than 2 years; 

10 (C) has a process for enrollment in services 

11 and benefits necessary by criminal justice agen12 cies to initiate or continue treatment in the com13 munity, under which an individual who is in14 carcerated may, while incarcerated, enroll in 

15 services and benefits that are necessary for the 

16 individual to continue treatment upon release 

17 from incarceration; 

18 (D) ensures the capability of data sharing 

19 with other States, such as by making data avail20 able to a prescription monitoring hub; 

21 (E) ensures that data recorded in the pre22 scription drug monitoring program database of 

23 the State is available within 24 hours, to the ex24 tent possible; and 

mstockstill on DSK4VPTVN1PROD with BILLS

156 

•S 524 RS

1 (F) ensures that the prescription drug mon2 itoring program of the State notifies prescribers 

3 and dispensers of schedule II, III, or IV con4 trolled substances when overuse or misuse of such 

5 controlled substances by patients is suspected. 

6 (c) AUTHORIZATION OF FUNDING.—For each of fiscal 

7 years 2016 through 2020, the Attorney General may use, 

8 from any unobligated balances made available under the 

9 heading ‘‘GENERAL ADMINISTRATION’’ to the Depart10 ment of Justice in an appropriations Act, such amounts 

11 as are necessary to carry out this section, not to exceed 

12 $5,000,000 per fiscal year. 

13 TITLE VII—MISCELLANEOUS 

14 SEC. 701. GAO REPORT ON IMD EXCLUSION. 

15 (a) DEFINITION.—In this section, the term ‘‘Medicaid 

16 Institutions for Mental Disease exclusion’’ means the prohi17 bition on Federal matching payments under Medicaid for 

18 patients who have attained age 22, but have not attained 

19 age 65, in an institution for mental diseases under subpara20 graph (B) of the matter following subsection (a) of section 

21 1905 of the Social Security Act and subsection (i) of such 

22 section (42 U.S.C. 1396d). 

23 (b) REPORT REQUIRED.—Not later than 1 year after 

24 the date of enactment of this Act, the Comptroller General 

25 of the United States shall submit to Congress a report on 

mstockstill on DSK4VPTVN1PROD with BILLS

157 

•S 524 RS

1 the impact that the Medicaid Institutions for Mental Dis2 ease exclusion has on access to treatment for individuals 

3 with a substance use disorder. 

4 (c) ELEMENTS.—The report required under subsection 

5 (b) shall include a review of what is known regarding— 

6 (1) Medicaid beneficiary access to substance use 

7 disorder treatments in institutions for mental disease; 

8 and 

9 (2) the quality of care provided to Medicaid 

10 beneficiaries treated in and outside of institutions for 

11 mental disease for substance use disorders. 

12 SEC. 702. FUNDING. 

13 Part II of title I of the Omnibus Crime Control and 

14 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as 

15 amended by section 501, is amended by adding at the end 

16 the following: 

17 ‘‘SEC. 2999F. FUNDING. 

18 ‘‘There are authorized to be appropriated to the Attor19 ney General and the Secretary of Health and Human Serv20 ices to carry out this part $77,900,000 for each of fiscal 

21 years 2016 through 2020.’’. 

22 SEC. 703. CONFORMING AMENDMENTS. 

23 Part II of title I of the Omnibus Crime Control and 

24 Safe Streets Act of 1968 (42 U.S.C. 3797cc et seq.) is 

25 amended— 

mstockstill on DSK4VPTVN1PROD with BILLS

158 

•S 524 RS

1 (1) in the part heading, by striking ‘‘CON2 FRONTING USE OF METHAMPHETAMINE’’ and 

3 inserting ‘‘COMPREHENSIVE ADDICTION AND RE4 COVERY’’; and 

5 (2) in section 2996(a)(1), by striking ‘‘this part’’ 

6 and inserting ‘‘this section’’. 

7 SEC. 704. GRANT ACCOUNTABILITY. 

8 (a) GRANTS UNDER PART II OF TITLE I OF THE OM9 NIBUS CRIME CONTROL AND SAFE STREETS ACT OF

10 1968.— 

11 Part II of title I of the Omnibus Crime Control 

12 and Safe Streets Act of 1968 (42 U.S.C. 3797cc et 

13 seq.), as amended by section 702, is amended by add14 ing at the end the following: 

15 ‘‘SEC. 2999G. GRANT ACCOUNTABILITY. 

16 ‘‘(a) DEFINITIONS.—In this section— 

17 ‘‘(1) the term ‘applicable committees’— 

18 ‘‘(A) with respect to the Attorney General 

19 and any other official of the Department of Jus20 tice, means— 

21 ‘‘(i) the Committee on the Judiciary of 

22 the Senate; and 

23 ‘‘(ii) the Committee on the Judiciary 

24 of the House of Representatives; and 

mstockstill on DSK4VPTVN1PROD with BILLS

159 

•S 524 RS

1 ‘‘(B) with respect to the Secretary of Health 

2 and Human Services and any other official of 

3 the Department of Health and Human Services, 

4 means— 

5 ‘‘(i) the Committee on Health, Edu6 cation, Labor, and Pensions of the Senate; 

7 and 

8 ‘‘(ii) the Committee on Energy and 

9 Commerce of the House of Representatives; 

10 ‘‘(2) the term ‘covered agency’ means— 

11 ‘‘(A) the Department of Justice; and 

12 ‘‘(B) the Department of Health and Human 

13 Services; and 

14 ‘‘(3) the term ‘covered official’ means— 

15 ‘‘(A) the Attorney General; and 

16 ‘‘(B) the Secretary of Health and Human 

17 Services. 

18 ‘‘(b) ACCOUNTABILITY.—All grants awarded by a cov19 ered official under this part shall be subject to the following 

20 accountability provisions: 

21 ‘‘(1) AUDIT REQUIREMENT.— 

22 ‘‘(A) DEFINITION.—In this paragraph, the 

23 term ‘unresolved audit finding’ means a finding 

24 in the final audit report of the Inspector General 

25 of a covered agency that the audited grantee has 

mstockstill on DSK4VPTVN1PROD with BILLS

160 

•S 524 RS

1 utilized grant funds for an unauthorized expend2 iture or otherwise unallowable cost that is not 

3 closed or resolved within 12 months after the 

4 date on which the final audit report is issued. 

5 ‘‘(B) AUDIT.—Beginning in the first fiscal 

6 year beginning after the date of enactment of 

7 this section, and in each fiscal year thereafter, 

8 the Inspector General of a covered agency shall 

9 conduct audits of recipients of grants awarded 

10 by the applicable covered official under this part 

11 to prevent waste, fraud, and abuse of funds by 

12 grantees. The Inspector General shall determine 

13 the appropriate number of grantees to be audited 

14 each year. 

15 ‘‘(C) MANDATORY EXCLUSION.—A recipient 

16 of grant funds under this part that is found to 

17 have an unresolved audit finding shall not be eli18 gible to receive grant funds under this part dur19 ing the first 2 fiscal years beginning after the 

20 end of the 12-month period described in subpara21 graph (A). 

22 ‘‘(D) PRIORITY.—In awarding grants under 

23 this part, a covered official shall give priority to 

24 eligible applicants that did not have an unre25 solved audit finding during the 3 fiscal years bemstockstill on DSK4VPTVN1PROD with BILLS

161 

•S 524 RS

1 fore submitting an application for a grant under 

2 this part. 

3 ‘‘(E) REIMBURSEMENT.—If an entity is 

4 awarded grant funds under this part during the 

5 2-fiscal-year period during which the entity is 

6 barred from receiving grants under subpara7 graph (C), the covered official that awarded the 

8 grant funds shall— 

9 ‘‘(i) deposit an amount equal to the 

10 amount of the grant funds that were im11 properly awarded to the grantee into the 

12 General Fund of the Treasury; and 

13 ‘‘(ii) seek to recoup the costs of the re14 payment to the fund from the grant recipi15 ent that was erroneously awarded grant 

16 funds. 

17 ‘‘(2) NONPROFIT ORGANIZATION REQUIRE18 MENTS.— 

19 ‘‘(A) DEFINITION.—For purposes of this 

20 paragraph and the grant programs under this 

21 part, the term ‘nonprofit organization’ means an 

22 organization that is described in section 

23 501(c)(3) of the Internal Revenue Code of 1986 

24 and is exempt from taxation under section 

25 501(a) of such Code. 

mstockstill on DSK4VPTVN1PROD with BILLS

162 

•S 524 RS

1 ‘‘(B) PROHIBITION.—A covered official may 

2 not award a grant under this part to a non3 profit organization that holds money in offshore 

4 accounts for the purpose of avoiding paying the 

5 tax described in section 511(a) of the Internal 

6 Revenue Code of 1986. 

7 ‘‘(C) DISCLOSURE.—Each nonprofit organi8 zation that is awarded a grant under this part 

9 and uses the procedures prescribed in regulations 

10 to create a rebuttable presumption of reasonable11 ness for the compensation of its officers, direc12 tors, trustees, and key employees, shall disclose to 

13 the applicable covered official, in the application 

14 for the grant, the process for determining such 

15 compensation, including the independent persons 

16 involved in reviewing and approving such com17 pensation, the comparability data used, and con18 temporaneous substantiation of the deliberation 

19 and decision. Upon request, a covered official 

20 shall make the information disclosed under this 

21 subparagraph available for public inspection. 

22 ‘‘(3) CONFERENCE EXPENDITURES.— 

23 ‘‘(A) LIMITATION.—No amounts made 

24 available to a covered official under this part 

25 may be used by the covered official, or by any 

mstockstill on DSK4VPTVN1PROD with BILLS

163 

•S 524 RS

1 individual or entity awarded discretionary funds 

2 through a cooperative agreement under this part, 

3 to host or support any expenditure for con4 ferences that uses more than $20,000 in funds 

5 made available by the covered official, unless the 

6 covered official provides prior written authoriza7 tion that the funds may be expended to host the 

8 conference. 

9 ‘‘(B) WRITTEN AUTHORIZATION.—Written 

10 authorization under subparagraph (A) shall in11 clude a written estimate of all costs associated 

12 with the conference, including the cost of all food, 

13 beverages, audio-visual equipment, honoraria for 

14 speakers, and entertainment. 

15 ‘‘(C) REPORT.— 

16 ‘‘(i) DEPARTMENT OF JUSTICE.—The 

17 Deputy Attorney General shall submit to 

18 the applicable committees an annual report 

19 on all conference expenditures approved by 

20 the Attorney General under this paragraph. 

21 ‘‘(ii) DEPARTMENT OF HEALTH AND

22 HUMAN SERVICES.—The Deputy Secretary 

23 of Health and Human Services shall submit 

24 to the applicable committees an annual re25 port on all conference expenditures apmstockstill on DSK4VPTVN1PROD with BILLS

164 

•S 524 RS

1 proved by the Secretary of Health and 

2 Human Services under this paragraph. 

3 ‘‘(4) ANNUAL CERTIFICATION.—Beginning in the 

4 first fiscal year beginning after the date of enactment 

5 of this section, each covered official shall submit to the 

6 applicable committees an annual certification— 

7 ‘‘(A) indicating whether— 

8 ‘‘(i) all audits issued by the Office of 

9 the Inspector General of the applicable 

10 agency under paragraph (1) have been com11 pleted and reviewed by the appropriate As12 sistant Attorney General or Director, or the 

13 appropriate official of the Department of 

14 Health and Human Services, as applicable; 

15 ‘‘(ii) all mandatory exclusions required 

16 under paragraph (1)(C) have been issued; 

17 and 

18 ‘‘(iii) all reimbursements required 

19 under paragraph (1)(E) have been made; 

20 and 

21 ‘‘(B) that includes a list of any grant re22 cipients excluded under paragraph (1) from the 

23 previous year. 

24 ‘‘(c) PREVENTING DUPLICATIVE GRANTS.— 

mstockstill on DSK4VPTVN1PROD with BILLS

165 

•S 524 RS

1 ‘‘(1) IN GENERAL.—Before a covered official 

2 awards a grant to an applicant under this part, the 

3 covered official shall compare potential grant awards 

4 with other grants awarded under this part by the cov5 ered official to determine if duplicate grant awards 

6 are awarded for the same purpose. 

7 ‘‘(2) REPORT.—If a covered official awards du8 plicate grants to the same applicant for the same pur9 pose, the covered official shall submit to the applicable 

10 committees a report that includes— 

11 ‘‘(A) a list of all duplicate grants awarded, 

12 including the total dollar amount of any dupli13 cate grants awarded; and 

14 ‘‘(B) the reason the covered official awarded 

15 the duplicate grants.’’. 

16 (b) OTHER GRANTS.— 

17 (1) DEFINITIONS.—In this subsection— 

18 (A) the term ‘‘applicable committees’’— 

19 (i) with respect to the Attorney Gen20 eral and any other official of the Depart21 ment of Justice, means— 

22 (I) the Committee on the Judici23 ary of the Senate; and 

mstockstill on DSK4VPTVN1PROD with BILLS

166 

•S 524 RS

1 (II) the Committee on the Judici2 ary of the House of Representatives; 

3 and 

4 (ii) with respect to the Secretary of 

5 Health and Human Services and any other 

6 official of the Department of Health and 

7 Human Services, means— 

8 (I) the Committee on Health, 

9 Education, Labor, and Pensions of the 

10 Senate; and 

11 (II) the Committee on Energy and 

12 Commerce of the House of Representa13 tives; 

14 (B) the term ‘‘covered agency’’ means— 

15 (i) the Department of Justice; and 

16 (ii) the Department of Health and 

17 Human Services; and 

18 (C) the term ‘‘covered official’’ means— 

19 (i) the Attorney General; and 

20 (ii) the Secretary of Health and 

21 Human Services. 

22 (2) ACCOUNTABILITY.—All grants awarded by a 

23 covered official under section 201, 302, or 601 shall 

24 be subject to the following accountability provisions: 

25 (A) AUDIT REQUIREMENT.— 

mstockstill on DSK4VPTVN1PROD with BILLS

167 

•S 524 RS

1 (i) DEFINITION.—In this subpara2 graph, the term ‘‘unresolved audit finding’’ 

3 means a finding in the final audit report of 

4 the Inspector General of a covered agency 

5 that the audited grantee has utilized grant 

6 funds for an unauthorized expenditure or 

7 otherwise unallowable cost that is not closed 

8 or resolved within 12 months after the date 

9 on which the final audit report is issued. 

10 (ii) AUDIT.—Beginning in the first fis11 cal year beginning after the date of enact12 ment of this Act, and in each fiscal year 

13 thereafter, the Inspector General of a cov14 ered agency shall conduct audits of recipi15 ents of grants awarded by the applicable 

16 covered official under section 201, 302, or 

17 601 to prevent waste, fraud, and abuse of 

18 funds by grantees. The Inspector General 

19 shall determine the appropriate number of 

20 grantees to be audited each year. 

21 (iii) MANDATORY EXCLUSION.—A re22 cipient of grant funds under section 201, 

23 302, or 601 that is found to have an unre24 solved audit finding shall not be eligible to 

25 receive grant funds under those sections 

mstockstill on DSK4VPTVN1PROD with BILLS

168 

•S 524 RS

1 during the first 2 fiscal years beginning 

2 after the end of the 12-month period de3 scribed in clause (i). 

4 (iv) PRIORITY.—In awarding grants 

5 under section 201, 302, or 601, a covered of6 ficial shall give priority to eligible appli7 cants that did not have an unresolved audit 

8 finding during the 3 fiscal years before sub9 mitting an application for a grant under 

10 such section. 

11 (v) REIMBURSEMENT.—If an entity is 

12 awarded grant funds under section 201, 

13 302, or 601 during the 2-fiscal-year period 

14 during which the entity is barred from re15 ceiving grants under clause (iii), the covered 

16 official that awarded the funds shall— 

17 (I) deposit an amount equal to the 

18 amount of the grant funds that were 

19 improperly awarded to the grantee into 

20 the General Fund of the Treasury; and 

21 (II) seek to recoup the costs of the 

22 repayment to the fund from the grant 

23 recipient that was erroneously awarded 

24 grant funds. 

mstockstill on DSK4VPTVN1PROD with BILLS

169 

•S 524 RS

1 (B) NONPROFIT ORGANIZATION REQUIRE2 MENTS.— 

3 (i) DEFINITION.—For purposes of this 

4 subparagraph and the grant programs 

5 under sections 201, 302, and 601, the term 

6 ‘‘nonprofit organization’’ means an organi7 zation that is described in section 501(c)(3) 

8 of the Internal Revenue Code of 1986 and is 

9 exempt from taxation under section 501(a) 

10 of such Code. 

11 (ii) PROHIBITION.—A covered official 

12 may not award a grant under this section 

13 201, 302, or 601 to a nonprofit organiza14 tion that holds money in offshore accounts 

15 for the purpose of avoiding paying the tax 

16 described in section 511(a) of the Internal 

17 Revenue Code of 1986. 

18 (iii) DISCLOSURE.—Each nonprofit or19 ganization that is awarded a grant under 

20 section 201, 302, or 601 and uses the proce21 dures prescribed in regulations to create a 

22 rebuttable presumption of reasonableness for 

23 the compensation of its officers, directors, 

24 trustees, and key employees, shall disclose to 

25 the applicable covered official, in the applimstockstill on DSK4VPTVN1PROD with BILLS

170 

•S 524 RS

1 cation for the grant, the process for deter2 mining such compensation, including the 

3 independent persons involved in reviewing 

4 and approving such compensation, the com5 parability data used, and contemporaneous 

6 substantiation of the deliberation and deci7 sion. Upon request, a covered official shall 

8 make the information disclosed under this 

9 clause available for public inspection. 

10 (C) CONFERENCE EXPENDITURES.— 

11 (i) LIMITATION.—No amounts made 

12 available to a covered official under section 

13 201, 302, or 601 may be used by the covered 

14 official, or by any individual or entity 

15 awarded discretionary funds through a co16 operative agreement under those sections, to 

17 host or support any expenditure for con18 ferences that uses more than $20,000 in 

19 funds made available by the covered official, 

20 unless the covered official provides prior 

21 written authorization that the funds may be 

22 expended to host the conference. 

23 (ii) WRITTEN AUTHORIZATION.—Writ24 ten authorization under clause (i) shall in25 clude a written estimate of all costs associmstockstill on DSK4VPTVN1PROD with BILLS

171 

•S 524 RS

1 ated with the conference, including the cost 

2 of all food, beverages, audio-visual equip3 ment, honoraria for speakers, and entertain4 ment. 

5 (iii) REPORT.— 

6 (I) DEPARTMENT OF JUSTICE.— 

7 The Deputy Attorney General shall 

8 submit to the applicable committees an 

9 annual report on all conference ex10 penditures approved by the Attorney 

11 General under this subparagraph. 

12 (II) DEPARTMENT OF HEALTH

13 AND HUMAN SERVICES.—The Deputy 

14 Secretary of Health and Human Serv15 ices shall submit to the applicable com16 mittees an annual report on all con17 ference expenditures approved by the 

18 Secretary of Health and Human Serv19 ices under this subparagraph. 

20 (D) ANNUAL CERTIFICATION.—Beginning 

21 in the first fiscal year beginning after the date 

22 of enactment of this Act, each covered official 

23 shall submit to the applicable committees an an24 nual certification— 

25 (i) indicating whether— 

mstockstill on DSK4VPTVN1PROD with BILLS

172 

•S 524 RS

1 (I) all audits issued by the Office 

2 of the Inspector General of the applica3 ble agency under subparagraph (A) 

4 have been completed and reviewed by 

5 the appropriate Assistant Attorney 

6 General or Director, or the appropriate 

7 official of the Department of Health 

8 and Human Services, as applicable; 

9 (II) all mandatory exclusions re10 quired under subparagraph (A)(iii) 

11 have been issued; and 

12 (III) all reimbursements required 

13 under subparagraph (A)(v) have been 

14 made; and 

15 (ii) that includes a list of any grant 

16 recipients excluded under subparagraph (A) 

17 from the previous year. 

18 (3) PREVENTING DUPLICATIVE GRANTS.— 

19 (A) IN GENERAL.—Before a covered official 

20 awards a grant to an applicant under section 

21 201, 302, or 601, the covered official shall com22 pare potential grant awards with other grants 

23 awarded under those sections by the covered offi24 cial to determine if duplicate grant awards are 

25 awarded for the same purpose. 

mstockstill on DSK4VPTVN1PROD with BILLS

173 

•S 524 RS

1 (B) REPORT.—If a covered official awards 

2 duplicate grants to the same applicant for the 

3 same purpose, the covered official shall submit to 

4 the to the applicable committees a report that in5 cludes— 

6 (i) a list of all duplicate grants award7 ed, including the total dollar amount of any 

8 duplicate grants awarded; and 

9 (ii) the reason the covered official 

10 awarded the duplicate grants. 

mstockstill on DSK4VPTVN1PROD with BILLS

Calendar No. 369 

114TH CONGRESS 

2D SESSION S. 524 

A BILL 

To authorize the Attorney General to award grants 

opioid abuse and heroin use. to address the national epidemics of prescription 

FEBRUARY 22, 2016 

Reported with an amendment 

mstockstill on DSK4VPTVN1PROD with BILLS